Frequencies for first 10,000 rows of pt variable in reac2017q4 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal discomfort | 17 0.17 0.17 Abdominal distension | 5 0.05 0.22 Abdominal infection | 1 0.01 0.23 Abdominal mass | 2 0.02 0.25 Abdominal operation | 1 0.01 0.26 Abdominal pain | 27 0.27 0.53 Abdominal pain lower | 5 0.05 0.58 Abdominal pain upper | 13 0.13 0.71 Abdominal wall disorder | 1 0.01 0.72 Abnormal behaviour | 7 0.07 0.79 Abnormal dreams | 3 0.03 0.82 Abnormal weight gain | 4 0.04 0.86 Abortion | 2 0.02 0.88 Abortion induced | 3 0.03 0.91 Abortion spontaneous | 3 0.03 0.94 Abscess | 1 0.01 0.95 Abscess jaw | 1 0.01 0.96 Abscess limb | 3 0.03 0.99 Abscess oral | 1 0.01 1.00 Accident | 2 0.02 1.02 Accidental exposure to product | 1 0.01 1.03 Accidental overdose | 4 0.04 1.07 Acetabulum fracture | 1 0.01 1.08 Acne | 2 0.02 1.10 Acne cystic | 1 0.01 1.11 Acquired claw toe | 1 0.01 1.12 Acquired mitochondrial DNA mutation | 1 0.01 1.13 Acral lentiginous melanoma | 1 0.01 1.14 Acrochordon | 1 0.01 1.15 Acute febrile neutrophilic dermatosis | 1 0.01 1.16 Acute hepatic failure | 1 0.01 1.17 Acute kidney injury | 21 0.21 1.38 Acute lymphocytic leukaemia | 1 0.01 1.39 Acute myeloid leukaemia | 2 0.02 1.41 Acute myocardial infarction | 3 0.03 1.44 Acute polyneuropathy | 1 0.01 1.45 Acute prerenal failure | 1 0.01 1.46 Acute promyelocytic leukaemia differe.. | 1 0.01 1.47 Acute psychosis | 1 0.01 1.48 Acute pulmonary oedema | 1 0.01 1.49 Acute respiratory distress syndrome | 6 0.06 1.55 Acute respiratory failure | 6 0.06 1.61 Acute sinusitis | 3 0.03 1.64 Adjustment disorder with depressed mood | 1 0.01 1.65 Adnexa uteri pain | 1 0.01 1.66 Adrenal insufficiency | 4 0.04 1.70 Adrenal neoplasm | 1 0.01 1.71 Adrenal suppression | 1 0.01 1.72 Adrenocorticotropic hormone deficiency | 2 0.02 1.74 Adverse drug reaction | 2 0.02 1.76 Adverse event | 15 0.15 1.91 Affect lability | 3 0.03 1.94 Affective disorder | 1 0.01 1.95 Ageusia | 2 0.02 1.97 Aggression | 11 0.11 2.08 Agitation | 22 0.22 2.30 Agoraphobia | 2 0.02 2.32 Agraphia | 1 0.01 2.33 Akathisia | 6 0.06 2.39 Akinesia | 1 0.01 2.40 Alanine aminotransferase increased | 16 0.16 2.56 Alcohol poisoning | 1 0.01 2.57 Alcohol use | 1 0.01 2.58 Allergic myocarditis | 1 0.01 2.59 Allergy test positive | 1 0.01 2.60 Allergy to animal | 1 0.01 2.61 Allergy to vaccine | 1 0.01 2.62 Alopecia | 22 0.22 2.84 Altered state of consciousness | 1 0.01 2.85 Altered visual depth perception | 1 0.01 2.86 Amblyopia | 1 0.01 2.87 Amenorrhoea | 1 0.01 2.88 Ammonia increased | 1 0.01 2.89 Amnesia | 12 0.12 3.01 Amylase increased | 3 0.03 3.04 Anaemia | 67 0.67 3.71 Anaemia of chronic disease | 1 0.01 3.72 Anaemia of pregnancy | 1 0.01 3.73 Anaemia postoperative | 15 0.15 3.88 Anaesthetic complication | 1 0.01 3.89 Anal abscess | 1 0.01 3.90 Anal atresia | 1 0.01 3.91 Anal fistula | 1 0.01 3.92 Anal incontinence | 2 0.02 3.94 Anal prolapse | 1 0.01 3.95 Analgesic drug level increased | 1 0.01 3.96 Anaphylactic reaction | 2 0.02 3.98 Anaphylactic shock | 1 0.01 3.99 Anaphylactoid syndrome of pregnancy | 1 0.01 4.00 Anastomotic leak | 1 0.01 4.01 Androgenetic alopecia | 1 0.01 4.02 Androgens abnormal | 1 0.01 4.03 Androgens decreased | 1 0.01 4.04 Aneurysm | 1 0.01 4.05 Anger | 5 0.05 4.10 Angina pectoris | 1 0.01 4.11 Angina unstable | 1 0.01 4.12 Angioedema | 4 0.04 4.16 Angiopathy | 4 0.04 4.20 Angle closure glaucoma | 1 0.01 4.21 Anhedonia | 1 0.01 4.22 Animal bite | 2 0.02 4.24 Ankle fracture | 19 0.19 4.43 Ankle operation | 1 0.01 4.44 Ankyloglossia congenital | 2 0.02 4.46 Anogenital warts | 1 0.01 4.47 Anomaly of orbit, congenital | 1 0.01 4.48 Anti-GAD antibody | 1 0.01 4.49 Anti-insulin antibody | 1 0.01 4.50 Antibody test abnormal | 1 0.01 4.51 Anticoagulation drug level below ther.. | 1 0.01 4.52 Anticoagulation drug level decreased | 1 0.01 4.53 Anticonvulsant drug level decreased | 1 0.01 4.54 Anxiety | 98 0.98 5.52 Anxiety disorder | 3 0.03 5.55 Aortic aneurysm | 2 0.02 5.57 Aortic aneurysm repair | 1 0.01 5.58 Aortic arteriosclerosis | 1 0.01 5.59 Aortic calcification | 1 0.01 5.60 Aortic dilatation | 1 0.01 5.61 Aortic stenosis | 2 0.02 5.63 Aortic valve replacement | 2 0.02 5.65 Aphasia | 1 0.01 5.66 Aphonia | 2 0.02 5.68 Apical granuloma | 1 0.01 5.69 Apicectomy | 1 0.01 5.70 Aplastic anaemia | 1 0.01 5.71 Apparent death | 2 0.02 5.73 Apparent life threatening event | 1 0.01 5.74 Appendicectomy | 6 0.06 5.80 Appendicitis | 6 0.06 5.86 Appetite disorder | 1 0.01 5.87 Application site burn | 1 0.01 5.88 Application site irritation | 2 0.02 5.90 Application site pruritus | 1 0.01 5.91 Application site pustules | 1 0.01 5.92 Application site rash | 2 0.02 5.94 Application site reaction | 1 0.01 5.95 Application site ulcer | 1 0.01 5.96 Application site urticaria | 1 0.01 5.97 Arachnoid cyst | 1 0.01 5.98 Arachnoiditis | 1 0.01 5.99 Arnold-Chiari malformation | 1 0.01 6.00 Arrhythmia | 13 0.13 6.13 Arterial occlusive disease | 2 0.02 6.15 Arterial stenosis | 1 0.01 6.16 Arteriosclerosis | 1 0.01 6.17 Arteriosclerosis coronary artery | 2 0.02 6.19 Arteriosclerotic retinopathy | 1 0.01 6.20 Arteriospasm coronary | 1 0.01 6.21 Arteritis | 1 0.01 6.22 Arthralgia | 65 0.65 6.87 Arthritis | 34 0.34 7.21 Arthrodesis | 2 0.02 7.23 Arthropathy | 17 0.17 7.40 Arthropod bite | 1 0.01 7.41 Arthropod sting | 1 0.01 7.42 Arthroscopy | 3 0.03 7.45 Asbestosis | 1 0.01 7.46 Ascites | 5 0.05 7.51 Aspartate aminotransferase increased | 18 0.18 7.69 Aspergillus infection | 3 0.03 7.72 Aspiration | 3 0.03 7.75 Aspiration joint | 1 0.01 7.76 Asthenia | 44 0.44 8.20 Asthma | 35 0.35 8.55 Asthmatic crisis | 1 0.01 8.56 Astigmatism | 1 0.01 8.57 Atelectasis | 8 0.08 8.65 Atrial fibrillation | 18 0.18 8.83 Atrial flutter | 2 0.02 8.85 Atrial septal defect | 3 0.03 8.88 Atrioventricular block first degree | 2 0.02 8.90 Atrioventricular block second degree | 1 0.01 8.91 Atrophic vulvovaginitis | 4 0.04 8.95 Attention deficit/hyperactivity disor.. | 6 0.06 9.01 Attention-seeking behaviour | 1 0.01 9.02 Aura | 2 0.02 9.04 Autism spectrum disorder | 5 0.05 9.09 Autoimmune hepatitis | 2 0.02 9.11 Axillary lymphadenectomy | 1 0.01 9.12 Axillary pain | 1 0.01 9.13 B-cell lymphoma | 2 0.02 9.15 BK virus infection | 1 0.01 9.16 Bacillus infection | 1 0.01 9.17 Back disorder | 6 0.06 9.23 Back injury | 3 0.03 9.26 Back pain | 63 0.63 9.89 Bacteraemia | 2 0.02 9.91 Bacterial infection | 6 0.06 9.97 Bacterial sepsis | 1 0.01 9.98 Balance disorder | 15 0.15 10.13 Barrett's oesophagus | 2 0.02 10.15 Bartholin's cyst | 1 0.01 10.16 Basal cell carcinoma | 2 0.02 10.18 Basal ganglia stroke | 1 0.01 10.19 Basedow's disease | 1 0.01 10.20 Benign breast neoplasm | 1 0.01 10.21 Benign neoplasm | 1 0.01 10.22 Benign neoplasm of eyelid | 1 0.01 10.23 Benign neoplasm of skin | 1 0.01 10.24 Benign prostatic hyperplasia | 1 0.01 10.25 Beta haemolytic streptococcal infection | 1 0.01 10.26 Bile acid malabsorption | 1 0.01 10.27 Bile duct stone | 2 0.02 10.29 Biliary colic | 1 0.01 10.30 Biopsy bone | 1 0.01 10.31 Biopsy bone abnormal | 1 0.01 10.32 Biopsy skin | 1 0.01 10.33 Bipolar I disorder | 3 0.03 10.36 Bipolar II disorder | 1 0.01 10.37 Bipolar disorder | 3 0.03 10.40 Bladder cancer | 3 0.03 10.43 Bladder disorder | 2 0.02 10.45 Bladder dysfunction | 3 0.03 10.48 Bladder outlet obstruction | 2 0.02 10.50 Bladder perforation | 1 0.01 10.51 Bladder prolapse | 1 0.01 10.52 Blepharoplasty | 1 0.01 10.53 Blepharospasm | 1 0.01 10.54 Blindness | 14 0.14 10.68 Blindness unilateral | 1 0.01 10.69 Blister | 9 0.09 10.78 Blood albumin decreased | 5 0.05 10.83 Blood albumin increased | 1 0.01 10.84 Blood alkaline phosphatase increased | 10 0.10 10.94 Blood beta-D-glucan increased | 1 0.01 10.95 Blood bicarbonate decreased | 1 0.01 10.96 Blood bilirubin increased | 8 0.08 11.04 Blood calcium decreased | 2 0.02 11.06 Blood calcium increased | 1 0.01 11.07 Blood chloride increased | 1 0.01 11.08 Blood cholesterol abnormal | 2 0.02 11.10 Blood cholesterol decreased | 2 0.02 11.12 Blood cholesterol increased | 27 0.27 11.39 Blood cholinesterase increased | 1 0.01 11.40 Blood count abnormal | 2 0.02 11.42 Blood creatine phosphokinase MB | 1 0.01 11.43 Blood creatine phosphokinase increased | 9 0.09 11.52 Blood creatinine decreased | 2 0.02 11.54 Blood creatinine increased | 20 0.20 11.74 Blood disorder | 3 0.03 11.77 Blood fibrinogen decreased | 1 0.01 11.78 Blood follicle stimulating hormone de.. | 1 0.01 11.79 Blood gases abnormal | 1 0.01 11.80 Blood glucose abnormal | 4 0.04 11.84 Blood glucose decreased | 4 0.04 11.88 Blood glucose fluctuation | 1 0.01 11.89 Blood glucose increased | 24 0.24 12.13 Blood gonadotrophin increased | 1 0.01 12.14 Blood immunoglobulin E increased | 1 0.01 12.15 Blood immunoglobulin G increased | 1 0.01 12.16 Blood iron decreased | 2 0.02 12.18 Blood lactate dehydrogenase increased | 11 0.11 12.29 Blood lactic acid increased | 2 0.02 12.31 Blood luteinising hormone decreased | 1 0.01 12.32 Blood magnesium decreased | 2 0.02 12.34 Blood pH increased | 1 0.01 12.35 Blood phosphorus decreased | 2 0.02 12.37 Blood potassium decreased | 7 0.07 12.44 Blood potassium increased | 1 0.01 12.45 Blood pressure abnormal | 1 0.01 12.46 Blood pressure decreased | 11 0.11 12.57 Blood pressure diastolic decreased | 2 0.02 12.59 Blood pressure diastolic increased | 1 0.01 12.60 Blood pressure fluctuation | 1 0.01 12.61 Blood pressure inadequately controlled | 1 0.01 12.62 Blood pressure increased | 28 0.28 12.90 Blood pressure systolic increased | 8 0.08 12.98 Blood prolactin decreased | 1 0.01 12.99 Blood sodium decreased | 5 0.05 13.04 Blood test abnormal | 2 0.02 13.06 Blood testosterone decreased | 1 0.01 13.07 Blood testosterone increased | 2 0.02 13.09 Blood thyroid stimulating hormone dec.. | 2 0.02 13.11 Blood triglycerides increased | 5 0.05 13.16 Blood urea increased | 8 0.08 13.24 Blood urea nitrogen/creatinine ratio .. | 1 0.01 13.25 Blood uric acid increased | 1 0.01 13.26 Body height abnormal | 2 0.02 13.28 Body height decreased | 9 0.09 13.37 Body temperature decreased | 3 0.03 13.40 Body temperature increased | 2 0.02 13.42 Body tinea | 2 0.02 13.44 Bone cyst | 1 0.01 13.45 Bone density decreased | 3 0.03 13.48 Bone disorder | 25 0.25 13.73 Bone erosion | 3 0.03 13.76 Bone graft | 3 0.03 13.79 Bone infarction | 1 0.01 13.80 Bone lesion | 1 0.01 13.81 Bone loss | 2 0.02 13.83 Bone marrow disorder | 1 0.01 13.84 Bone marrow failure | 3 0.03 13.87 Bone pain | 13 0.13 14.00 Bone scan abnormal | 1 0.01 14.01 Bowel movement irregularity | 1 0.01 14.02 Bradycardia | 9 0.09 14.11 Bradycardia foetal | 1 0.01 14.12 Bradykinesia | 2 0.02 14.14 Bradyphrenia | 1 0.01 14.15 Brain abscess | 4 0.04 14.19 Brain cancer metastatic | 1 0.01 14.20 Brain death | 2 0.02 14.22 Brain herniation | 2 0.02 14.24 Brain injury | 5 0.05 14.29 Brain natriuretic peptide increased | 1 0.01 14.30 Brain neoplasm | 3 0.03 14.33 Brain oedema | 2 0.02 14.35 Breast abscess | 1 0.01 14.36 Breast calcifications | 1 0.01 14.37 Breast cancer | 4 0.04 14.41 Breast cancer female | 1 0.01 14.42 Breast cancer metastatic | 3 0.03 14.45 Breast cancer stage II | 1 0.01 14.46 Breast cancer stage III | 1 0.01 14.47 Breast cyst | 1 0.01 14.48 Breast cyst excision | 1 0.01 14.49 Breast disorder | 2 0.02 14.51 Breast mass | 1 0.01 14.52 Breast necrosis | 1 0.01 14.53 Breast pain | 3 0.03 14.56 Breast tenderness | 2 0.02 14.58 Breath sounds abnormal | 1 0.01 14.59 Breech presentation | 1 0.01 14.60 Bronchial disorder | 1 0.01 14.61 Bronchial hyperreactivity | 2 0.02 14.63 Bronchial obstruction | 1 0.01 14.64 Bronchiectasis | 1 0.01 14.65 Bronchitis | 15 0.15 14.80 Bronchitis chronic | 1 0.01 14.81 Bronchopulmonary aspergillosis | 1 0.01 14.82 Bronchospasm | 1 0.01 14.83 Bundle branch block left | 1 0.01 14.84 Bundle branch block right | 2 0.02 14.86 Bunion operation | 2 0.02 14.88 Burning sensation | 5 0.05 14.93 Bursitis | 20 0.20 15.13 C-reactive protein abnormal | 1 0.01 15.14 C-reactive protein increased | 13 0.13 15.27 Cachexia | 1 0.01 15.28 Caesarean section | 1 0.01 15.29 Cafe au lait spots | 1 0.01 15.30 Calcium deficiency | 7 0.07 15.37 Calculus urinary | 1 0.01 15.38 Cancer pain | 2 0.02 15.40 Cancer surgery | 1 0.01 15.41 Candida infection | 1 0.01 15.42 Capillary leak syndrome | 1 0.01 15.43 Carbohydrate antigen 125 increased | 1 0.01 15.44 Carbon dioxide increased | 1 0.01 15.45 Carcinoid syndrome | 1 0.01 15.46 Carcinoid tumour | 1 0.01 15.47 Cardiac aneurysm | 1 0.01 15.48 Cardiac arrest | 10 0.10 15.58 Cardiac disorder | 16 0.16 15.74 Cardiac failure | 19 0.19 15.93 Cardiac failure chronic | 1 0.01 15.94 Cardiac failure congestive | 10 0.10 16.04 Cardiac hypertrophy | 1 0.01 16.05 Cardiac murmur | 4 0.04 16.09 Cardiac operation | 1 0.01 16.10 Cardiac valve disease | 1 0.01 16.11 Cardio-respiratory arrest | 4 0.04 16.15 Cardiogenic shock | 3 0.03 16.18 Cardiomegaly | 1 0.01 16.19 Cardiomyopathy | 2 0.02 16.21 Cardiospasm | 1 0.01 16.22 Cardiotoxicity | 1 0.01 16.23 Cardiovascular disorder | 4 0.04 16.27 Cardiovascular insufficiency | 1 0.01 16.28 Cardioversion | 1 0.01 16.29 Carotid arteriosclerosis | 1 0.01 16.30 Carotid artery disease | 1 0.01 16.31 Carotid artery stenosis | 2 0.02 16.33 Carotid endarterectomy | 1 0.01 16.34 Carpal tunnel decompression | 2 0.02 16.36 Carpal tunnel syndrome | 6 0.06 16.42 Cartilage injury | 1 0.01 16.43 Cataract | 21 0.21 16.64 Cataract operation | 7 0.07 16.71 Catatonia | 2 0.02 16.73 Catheter site erythema | 1 0.01 16.74 Catheter site infection | 1 0.01 16.75 Catheter site pruritus | 1 0.01 16.76 Cell marker increased | 3 0.03 16.79 Cellulitis | 15 0.15 16.94 Central nervous system haemorrhage | 1 0.01 16.95 Central nervous system lesion | 6 0.06 17.01 Central nervous system lymphoma | 1 0.01 17.02 Cerebellar infarction | 1 0.01 17.03 Cerebral artery thrombosis | 1 0.01 17.04 Cerebral disorder | 1 0.01 17.05 Cerebral haematoma | 2 0.02 17.07 Cerebral haemorrhage | 10 0.10 17.17 Cerebral infarction | 6 0.06 17.23 Cerebral ischaemia | 2 0.02 17.25 Cerebral palsy | 1 0.01 17.26 Cerebral small vessel ischaemic disease | 1 0.01 17.27 Cerebral thrombosis | 2 0.02 17.29 Cerebral ventricle dilatation | 1 0.01 17.30 Cerebral ventricular rupture | 1 0.01 17.31 Cerebrospinal fluid leakage | 1 0.01 17.32 Cerebrovascular accident | 23 0.23 17.55 Cerumen impaction | 1 0.01 17.56 Cervical radiculopathy | 1 0.01 17.57 Cervical spinal stenosis | 2 0.02 17.59 Change of bowel habit | 1 0.01 17.60 Cheilitis | 1 0.01 17.61 Chest X-ray abnormal | 1 0.01 17.62 Chest discomfort | 11 0.11 17.73 Chest injury | 2 0.02 17.75 Chest pain | 34 0.34 18.09 Chills | 12 0.12 18.21 Choking | 2 0.02 18.23 Choking sensation | 2 0.02 18.25 Cholangitis | 4 0.04 18.29 Cholangitis sclerosing | 1 0.01 18.30 Cholecystectomy | 7 0.07 18.37 Cholecystitis | 2 0.02 18.39 Cholecystitis acute | 2 0.02 18.41 Cholecystitis chronic | 1 0.01 18.42 Cholelithiasis | 3 0.03 18.45 Cholestasis | 2 0.02 18.47 Cholestasis of pregnancy | 1 0.01 18.48 Cholesteatoma | 1 0.01 18.49 Chondrocalcinosis | 2 0.02 18.51 Chondromalacia | 1 0.01 18.52 Chondropathy | 1 0.01 18.53 Chorea | 1 0.01 18.54 Choroidal neovascularisation | 1 0.01 18.55 Chromaturia | 4 0.04 18.59 Chronic gastritis | 2 0.02 18.61 Chronic kidney disease | 11 0.11 18.72 Chronic myeloid leukaemia | 5 0.05 18.77 Chronic obstructive pulmonary disease | 21 0.21 18.98 Circumstance or information capable o.. | 1 0.01 18.99 Circumstance or information capable o.. | 2 0.02 19.01 Cirrhosis alcoholic | 1 0.01 19.02 Claustrophobia | 1 0.01 19.03 Clear cell renal cell carcinoma | 1 0.01 19.04 Clinodactyly | 2 0.02 19.06 Closed fracture manipulation | 2 0.02 19.08 Clostridial infection | 1 0.01 19.09 Clostridium difficile colitis | 3 0.03 19.12 Clostridium difficile infection | 4 0.04 19.16 Clumsiness | 1 0.01 19.17 Cluster headache | 1 0.01 19.18 Coagulation factor VII level increased | 1 0.01 19.19 Coagulation time prolonged | 1 0.01 19.20 Coagulopathy | 2 0.02 19.22 Cognitive disorder | 5 0.05 19.27 Colitis | 9 0.09 19.36 Colitis ulcerative | 1 0.01 19.37 Colon adenoma | 3 0.03 19.40 Colon cancer | 4 0.04 19.44 Colour blindness | 1 0.01 19.45 Coma | 6 0.06 19.51 Coma hepatic | 1 0.01 19.52 Comminuted fracture | 2 0.02 19.54 Completed suicide | 6 0.06 19.60 Complex regional pain syndrome | 2 0.02 19.62 Complication associated with device | 5 0.05 19.67 Complication of device insertion | 1 0.01 19.68 Complication of device removal | 1 0.01 19.69 Compression fracture | 12 0.12 19.81 Compulsions | 1 0.01 19.82 Compulsive shopping | 2 0.02 19.84 Computerised tomogram thorax abnormal | 1 0.01 19.85 Concomitant disease aggravated | 5 0.05 19.90 Concussion | 1 0.01 19.91 Condition aggravated | 24 0.24 20.15 Conductive deafness | 1 0.01 20.16 Confusional state | 21 0.21 20.37 Congenital anomaly | 1 0.01 20.38 Congenital cystic kidney disease | 1 0.01 20.39 Congenital eyelid malformation | 1 0.01 20.40 Congenital hair disorder | 1 0.01 20.41 Congenital hand malformation | 1 0.01 20.42 Congenital multiplex arthrogryposis | 1 0.01 20.43 Congenital oral malformation | 1 0.01 20.44 Congestive cardiomyopathy | 2 0.02 20.46 Conjunctival haemorrhage | 2 0.02 20.48 Conjunctival hyperaemia | 1 0.01 20.49 Conjunctival irritation | 1 0.01 20.50 Conjunctivitis | 2 0.02 20.52 Consciousness fluctuating | 1 0.01 20.53 Constipation | 23 0.23 20.76 Contusion | 16 0.16 20.92 Cor pulmonale | 2 0.02 20.94 Coronary artery disease | 13 0.13 21.07 Coronary artery occlusion | 2 0.02 21.09 Cortisol decreased | 1 0.01 21.10 Cortisol increased | 3 0.03 21.13 Cough | 47 0.47 21.60 Craniocerebral injury | 1 0.01 21.61 Creatinine renal clearance abnormal | 1 0.01 21.62 Creatinine renal clearance decreased | 1 0.01 21.63 Crohn's disease | 9 0.09 21.72 Croup infectious | 1 0.01 21.73 Crying | 2 0.02 21.75 Cryoglobulinaemia | 1 0.01 21.76 Cryptorchism | 1 0.01 21.77 Cyanopsia | 1 0.01 21.78 Cyanosis | 4 0.04 21.82 Cyst | 2 0.02 21.84 Cyst removal | 2 0.02 21.86 Cystic fibrosis | 1 0.01 21.87 Cystitis | 7 0.07 21.94 Cystitis interstitial | 1 0.01 21.95 Cystitis viral | 1 0.01 21.96 Cystocele | 5 0.05 22.01 Cytogenetic analysis abnormal | 2 0.02 22.03 Cytomegalovirus chorioretinitis | 1 0.01 22.04 Cytomegalovirus infection | 3 0.03 22.07 Cytopenia | 4 0.04 22.11 Cytotoxic cardiomyopathy | 1 0.01 22.12 Dacryostenosis acquired | 1 0.01 22.13 Deafness | 9 0.09 22.22 Deafness bilateral | 1 0.01 22.23 Deafness neurosensory | 2 0.02 22.25 Death | 40 0.40 22.65 Debridement | 1 0.01 22.66 Decreased activity | 1 0.01 22.67 Decreased appetite | 22 0.22 22.89 Decreased interest | 3 0.03 22.92 Decreased vibratory sense | 1 0.01 22.93 Decubitus ulcer | 3 0.03 22.96 Deep vein thrombosis | 19 0.19 23.15 Deformity | 2 0.02 23.17 Dehydration | 19 0.19 23.36 Delirium | 8 0.08 23.44 Delusion | 9 0.09 23.53 Dementia | 5 0.05 23.58 Dementia Alzheimer's type | 1 0.01 23.59 Dengue fever | 1 0.01 23.60 Dental care | 1 0.01 23.61 Dental caries | 5 0.05 23.66 Dental fistula | 1 0.01 23.67 Dental implantation | 1 0.01 23.68 Dental leakage | 1 0.01 23.69 Dental necrosis | 1 0.01 23.70 Depressed level of consciousness | 4 0.04 23.74 Depressed mood | 5 0.05 23.79 Depression | 68 0.68 24.47 Depression suicidal | 1 0.01 24.48 Dermatitis | 6 0.06 24.54 Dermatitis acneiform | 3 0.03 24.57 Dermatitis bullous | 1 0.01 24.58 Dermatitis contact | 2 0.02 24.60 Dermatitis exfoliative | 2 0.02 24.62 Dermoid cyst | 1 0.01 24.63 Developmental delay | 3 0.03 24.66 Device breakage | 1 0.01 24.67 Device difficult to use | 2 0.02 24.69 Device dislocation | 1 0.01 24.70 Device expulsion | 1 0.01 24.71 Device failure | 5 0.05 24.76 Device intolerance | 1 0.01 24.77 Device issue | 3 0.03 24.80 Device malfunction | 1 0.01 24.81 Device occlusion | 1 0.01 24.82 Device related infection | 3 0.03 24.85 Diabetes mellitus | 30 0.30 25.15 Diabetes mellitus inadequate control | 3 0.03 25.18 Diabetic coma | 1 0.01 25.19 Diabetic microangiopathy | 1 0.01 25.20 Diabetic neuropathy | 2 0.02 25.22 Diaphragmalgia | 1 0.01 25.23 Diarrhoea | 76 0.76 25.99 Diarrhoea haemorrhagic | 3 0.03 26.02 Diastolic dysfunction | 1 0.01 26.03 Differential white blood cell count a.. | 1 0.01 26.04 Diffuse large B-cell lymphoma | 1 0.01 26.05 Diplegia | 1 0.01 26.06 Diplopia | 7 0.07 26.13 Disability | 1 0.01 26.14 Discomfort | 8 0.08 26.22 Disease complication | 2 0.02 26.24 Disease progression | 8 0.08 26.32 Disease recurrence | 2 0.02 26.34 Disinhibition | 1 0.01 26.35 Disorientation | 9 0.09 26.44 Disseminated intravascular coagulation | 6 0.06 26.50 Disturbance in attention | 5 0.05 26.55 Disturbance in social behaviour | 2 0.02 26.57 Diverticular perforation | 1 0.01 26.58 Diverticulitis | 7 0.07 26.65 Diverticulum | 9 0.09 26.74 Diverticulum intestinal | 3 0.03 26.77 Dizziness | 47 0.47 27.24 Dizziness postural | 1 0.01 27.25 Drug abuse | 3 0.03 27.28 Drug administered at inappropriate site | 1 0.01 27.29 Drug administered in wrong device | 1 0.01 27.30 Drug administered to patient of inapp.. | 3 0.03 27.33 Drug administration error | 2 0.02 27.35 Drug clearance decreased | 1 0.01 27.36 Drug dependence | 9 0.09 27.45 Drug dispensing error | 1 0.01 27.46 Drug diversion | 1 0.01 27.47 Drug dose omission | 48 0.48 27.95 Drug effect decreased | 7 0.07 28.02 Drug effect delayed | 1 0.01 28.03 Drug effect incomplete | 5 0.05 28.08 Drug effect increased | 2 0.02 28.10 Drug eruption | 3 0.03 28.13 Drug hypersensitivity | 38 0.38 28.51 Drug ineffective | 63 0.63 29.14 Drug ineffective for unapproved indic.. | 2 0.02 29.16 Drug interaction | 23 0.23 29.39 Drug intolerance | 10 0.10 29.49 Drug level above therapeutic | 1 0.01 29.50 Drug level increased | 3 0.03 29.53 Drug prescribing error | 4 0.04 29.57 Drug reaction with eosinophilia and s.. | 6 0.06 29.63 Drug resistance | 2 0.02 29.65 Drug specific antibody | 1 0.01 29.66 Drug specific antibody present | 1 0.01 29.67 Drug therapy | 1 0.01 29.68 Drug withdrawal syndrome | 6 0.06 29.74 Drug withdrawal syndrome neonatal | 1 0.01 29.75 Drug-induced liver injury | 2 0.02 29.77 Dry eye | 4 0.04 29.81 Dry mouth | 8 0.08 29.89 Dry skin | 10 0.10 29.99 Duodenal ulcer | 1 0.01 30.00 Duodenal ulcer perforation | 1 0.01 30.01 Duodenitis | 2 0.02 30.03 Dysarthria | 4 0.04 30.07 Dyschezia | 1 0.01 30.08 Dysentery | 1 0.01 30.09 Dysgeusia | 3 0.03 30.12 Dysgraphia | 1 0.01 30.13 Dyskinesia | 6 0.06 30.19 Dyslipidaemia | 11 0.11 30.30 Dysmorphism | 4 0.04 30.34 Dyspareunia | 1 0.01 30.35 Dyspepsia | 18 0.18 30.53 Dysphagia | 12 0.12 30.65 Dysphonia | 7 0.07 30.72 Dysphoria | 1 0.01 30.73 Dyspnoea | 77 0.77 31.50 Dyspnoea at rest | 1 0.01 31.51 Dyspnoea exertional | 4 0.04 31.55 Dyspraxia | 4 0.04 31.59 Dysstasia | 8 0.08 31.67 Dystonia | 2 0.02 31.69 Dysuria | 4 0.04 31.73 Ear discomfort | 1 0.01 31.74 Ear haemorrhage | 1 0.01 31.75 Ear infection | 4 0.04 31.79 Ear malformation | 1 0.01 31.80 Ear operation | 1 0.01 31.81 Ear pain | 3 0.03 31.84 Early retirement | 1 0.01 31.85 Eating disorder | 4 0.04 31.89 Ecchymosis | 3 0.03 31.92 Economic problem | 1 0.01 31.93 Ecthyma | 1 0.01 31.94 Ectopic ACTH syndrome | 1 0.01 31.95 Eczema | 6 0.06 32.01 Eczema asteatotic | 2 0.02 32.03 Effusion | 1 0.01 32.04 Ejaculation disorder | 2 0.02 32.06 Ejaculation failure | 2 0.02 32.08 Electrocardiogram PR prolongation | 1 0.01 32.09 Electrocardiogram QT prolonged | 3 0.03 32.12 Electrocardiogram ST segment abnormal | 1 0.01 32.13 Electrocardiogram abnormal | 2 0.02 32.15 Electrocardiogram change | 1 0.01 32.16 Electrolyte imbalance | 1 0.01 32.17 Embedded device | 1 0.01 32.18 Embolic stroke | 2 0.02 32.20 Embolism | 6 0.06 32.26 Emotional disorder | 4 0.04 32.30 Emotional distress | 46 0.46 32.76 Emphysema | 5 0.05 32.81 Encephalitis | 1 0.01 32.82 Encephalitis cytomegalovirus | 1 0.01 32.83 Encephalopathy | 6 0.06 32.89 Enchondromatosis | 1 0.01 32.90 End stage renal disease | 1 0.01 32.91 Endocarditis | 2 0.02 32.93 Endodontic procedure | 4 0.04 32.97 Endometrial adenocarcinoma | 1 0.01 32.98 Endophthalmitis | 2 0.02 33.00 Engraft failure | 1 0.01 33.01 Enteritis | 1 0.01 33.02 Enteritis infectious | 2 0.02 33.04 Enterobacter infection | 1 0.01 33.05 Enterocele | 1 0.01 33.06 Enterocolitis | 2 0.02 33.08 Enthesopathy | 3 0.03 33.11 Enuresis | 1 0.01 33.12 Enzyme inhibition | 1 0.01 33.13 Eosinophil count increased | 3 0.03 33.16 Eosinophilia | 2 0.02 33.18 Eosinophilic granulomatosis with poly.. | 1 0.01 33.19 Eosinophilic oesophagitis | 1 0.01 33.20 Eosinophilic pneumonia | 1 0.01 33.21 Epidermolysis | 1 0.01 33.22 Epigastric discomfort | 2 0.02 33.24 Epilepsy | 4 0.04 33.28 Epistaxis | 13 0.13 33.41 Epstein-Barr virus antibody positive | 1 0.01 33.42 Erectile dysfunction | 7 0.07 33.49 Eructation | 1 0.01 33.50 Erysipelas | 5 0.05 33.55 Erythema | 15 0.15 33.70 Erythema multiforme | 2 0.02 33.72 Erythropsia | 1 0.01 33.73 Escherichia infection | 1 0.01 33.74 Escherichia urinary tract infection | 1 0.01 33.75 Essential hypertension | 6 0.06 33.81 Euphoric mood | 3 0.03 33.84 Eustachian tube dysfunction | 1 0.01 33.85 Exfoliative rash | 1 0.01 33.86 Exostosis | 7 0.07 33.93 Expanded disability status scale scor.. | 1 0.01 33.94 Expired product administered | 1 0.01 33.95 Explorative laparotomy | 1 0.01 33.96 Exposed bone in jaw | 2 0.02 33.98 Exposure during breast feeding | 2 0.02 34.00 Exposure during pregnancy | 3 0.03 34.03 Exposure to communicable disease | 1 0.01 34.04 External ear inflammation | 1 0.01 34.05 Extrapyramidal disorder | 2 0.02 34.07 Extraskeletal ossification | 2 0.02 34.09 Extremity necrosis | 1 0.01 34.10 Eye discharge | 2 0.02 34.12 Eye disorder | 6 0.06 34.18 Eye haemorrhage | 2 0.02 34.20 Eye infection | 3 0.03 34.23 Eye inflammation | 2 0.02 34.25 Eye injury | 1 0.01 34.26 Eye irritation | 1 0.01 34.27 Eye movement disorder | 2 0.02 34.29 Eye muscle operation | 1 0.01 34.30 Eye operation | 1 0.01 34.31 Eye pain | 3 0.03 34.34 Eye swelling | 2 0.02 34.36 Eyelid disorder | 1 0.01 34.37 Eyelid function disorder | 1 0.01 34.38 Eyelid oedema | 5 0.05 34.43 Eyelid ptosis | 3 0.03 34.46 Face injury | 1 0.01 34.47 Face oedema | 3 0.03 34.50 Facet joint syndrome | 1 0.01 34.51 Facial bones fracture | 1 0.01 34.52 Facial pain | 2 0.02 34.54 Facial paralysis | 3 0.03 34.57 Facial paresis | 1 0.01 34.58 Faecaloma | 1 0.01 34.59 Faeces discoloured | 3 0.03 34.62 Faeces hard | 1 0.01 34.63 Faeces pale | 1 0.01 34.64 Failure to thrive | 1 0.01 34.65 Fall | 97 0.97 35.62 Fallopian tube obstruction | 1 0.01 35.63 Fatigue | 86 0.86 36.49 Fear | 4 0.04 36.53 Fear of injection | 1 0.01 36.54 Febrile infection | 1 0.01 36.55 Febrile neutropenia | 14 0.14 36.69 Feeding disorder | 4 0.04 36.73 Feeling abnormal | 27 0.27 37.00 Feeling cold | 2 0.02 37.02 Feeling guilty | 1 0.01 37.03 Feeling hot | 3 0.03 37.06 Feeling of body temperature change | 3 0.03 37.09 Feeling of despair | 1 0.01 37.10 Female orgasmic disorder | 1 0.01 37.11 Female sterilisation | 1 0.01 37.12 Femoral hernia | 1 0.01 37.13 Femoral hernia repair | 1 0.01 37.14 Femoral neck fracture | 2 0.02 37.16 Femur fracture | 163 1.63 38.79 Fibrin D dimer increased | 2 0.02 38.81 Fibroadenoma of breast | 1 0.01 38.82 Fibrocystic breast disease | 2 0.02 38.84 Fibromyalgia | 8 0.08 38.92 Fibrosis | 1 0.01 38.93 Fibula fracture | 8 0.08 39.01 Finger deformity | 6 0.06 39.07 Fistula | 4 0.04 39.11 Flatulence | 1 0.01 39.12 Fluid overload | 1 0.01 39.13 Fluid retention | 10 0.10 39.23 Flushing | 1 0.01 39.24 Foaming at mouth | 1 0.01 39.25 Focal dyscognitive seizures | 1 0.01 39.26 Focal segmental glomerulosclerosis | 1 0.01 39.27 Foetal anticonvulsant syndrome | 3 0.03 39.30 Foetal arrhythmia | 1 0.01 39.31 Foetal death | 2 0.02 39.33 Foetal disorder | 1 0.01 39.34 Foetal exposure during delivery | 1 0.01 39.35 Foetal exposure during pregnancy | 18 0.18 39.53 Foetal growth restriction | 1 0.01 39.54 Food allergy | 1 0.01 39.55 Food intolerance | 1 0.01 39.56 Food poisoning | 2 0.02 39.58 Foot deformity | 12 0.12 39.70 Foot fracture | 29 0.29 39.99 Foot operation | 4 0.04 40.03 Foreign body in eye | 1 0.01 40.04 Formication | 3 0.03 40.07 Fracture | 8 0.08 40.15 Fracture delayed union | 7 0.07 40.22 Fracture displacement | 1 0.01 40.23 Fracture nonunion | 8 0.08 40.31 Fracture pain | 1 0.01 40.32 Fractured coccyx | 2 0.02 40.34 Fractured sacrum | 2 0.02 40.36 Frontotemporal dementia | 1 0.01 40.37 Frustration tolerance decreased | 1 0.01 40.38 Fundoscopy abnormal | 1 0.01 40.39 Fungal infection | 6 0.06 40.45 Fungal skin infection | 1 0.01 40.46 Gait disturbance | 44 0.44 40.90 Gait inability | 6 0.06 40.96 Galactorrhoea | 1 0.01 40.97 Gallbladder adenocarcinoma | 1 0.01 40.98 Gambling disorder | 1 0.01 40.99 Gamma-glutamyltransferase | 1 0.01 41.00 Gamma-glutamyltransferase increased | 12 0.12 41.12 Gastrectomy | 1 0.01 41.13 Gastric antral vascular ectasia | 1 0.01 41.14 Gastric cancer | 2 0.02 41.16 Gastric dilatation | 1 0.01 41.17 Gastric disorder | 3 0.03 41.20 Gastric haemorrhage | 2 0.02 41.22 Gastric pH decreased | 1 0.01 41.23 Gastric perforation | 1 0.01 41.24 Gastric polyps | 1 0.01 41.25 Gastric ulcer | 5 0.05 41.30 Gastric ulcer haemorrhage | 2 0.02 41.32 Gastric ulcer perforation | 1 0.01 41.33 Gastritis | 10 0.10 41.43 Gastritis erosive | 1 0.01 41.44 Gastroenteritis | 7 0.07 41.51 Gastroenteritis viral | 1 0.01 41.52 Gastrointestinal disorder | 9 0.09 41.61 Gastrointestinal erosion | 1 0.01 41.62 Gastrointestinal haemorrhage | 16 0.16 41.78 Gastrointestinal infection | 3 0.03 41.81 Gastrointestinal motility disorder | 3 0.03 41.84 Gastrointestinal neoplasm | 1 0.01 41.85 Gastrointestinal pain | 1 0.01 41.86 Gastrointestinal toxicity | 2 0.02 41.88 Gastrointestinal ulcer | 1 0.01 41.89 Gastrooesophageal reflux disease | 40 0.40 42.29 Gaze palsy | 1 0.01 42.30 Gene mutation | 1 0.01 42.31 General physical condition abnormal | 2 0.02 42.33 General physical health deterioration | 25 0.25 42.58 Generalised erythema | 2 0.02 42.60 Generalised oedema | 5 0.05 42.65 Generalised tonic-clonic seizure | 1 0.01 42.66 Genital disorder male | 1 0.01 42.67 Genital haemorrhage | 2 0.02 42.69 Genital herpes | 1 0.01 42.70 Genital hypoaesthesia | 1 0.01 42.71 Genital ulceration | 2 0.02 42.73 Gingival recession | 1 0.01 42.74 Gingivitis | 1 0.01 42.75 Glaucoma | 7 0.07 42.82 Glomerular filtration rate increased | 1 0.01 42.83 Glucose tolerance impaired | 4 0.04 42.87 Glycosylated haemoglobin increased | 6 0.06 42.93 Goitre | 5 0.05 42.98 Gonorrhoea | 1 0.01 42.99 Gout | 4 0.04 43.03 Graft complication | 1 0.01 43.04 Graft versus host disease in gastroin.. | 1 0.01 43.05 Grip strength decreased | 1 0.01 43.06 Groin pain | 4 0.04 43.10 Growth retardation | 3 0.03 43.13 Gynaecomastia | 4 0.04 43.17 Haemangioma | 1 0.01 43.18 Haemarthrosis | 2 0.02 43.20 Haematemesis | 2 0.02 43.22 Haematochezia | 6 0.06 43.28 Haematocrit decreased | 2 0.02 43.30 Haematoma | 6 0.06 43.36 Haematoma infection | 1 0.01 43.37 Haematotoxicity | 1 0.01 43.38 Haematuria | 8 0.08 43.46 Haemodynamic instability | 1 0.01 43.47 Haemoglobin | 1 0.01 43.48 Haemoglobin decreased | 19 0.19 43.67 Haemolysis | 5 0.05 43.72 Haemolytic uraemic syndrome | 1 0.01 43.73 Haemoptysis | 4 0.04 43.77 Haemorrhage | 14 0.14 43.91 Haemorrhage intracranial | 5 0.05 43.96 Haemorrhage subcutaneous | 1 0.01 43.97 Haemorrhagic anaemia | 9 0.09 44.06 Haemorrhagic stroke | 3 0.03 44.09 Haemorrhoids | 8 0.08 44.17 Haemosiderosis | 1 0.01 44.18 Hair disorder | 1 0.01 44.19 Hair growth abnormal | 1 0.01 44.20 Hair texture abnormal | 1 0.01 44.21 Hallucination | 10 0.10 44.31 Hallucination, auditory | 4 0.04 44.35 Hallucination, visual | 3 0.03 44.38 Hallucinations, mixed | 1 0.01 44.39 Hand deformity | 3 0.03 44.42 Hand fracture | 6 0.06 44.48 Hand repair operation | 1 0.01 44.49 Head circumference abnormal | 1 0.01 44.50 Head discomfort | 2 0.02 44.52 Head injury | 6 0.06 44.58 Headache | 70 0.70 45.28 Heart disease congenital | 2 0.02 45.30 Heart rate decreased | 8 0.08 45.38 Heart rate increased | 16 0.16 45.54 Heart rate irregular | 6 0.06 45.60 Heart valve incompetence | 2 0.02 45.62 Heat stroke | 2 0.02 45.64 Hemianaesthesia | 1 0.01 45.65 Hemiparesis | 2 0.02 45.67 Hemiplegia | 1 0.01 45.68 Hepatectomy | 1 0.01 45.69 Hepatic cancer | 3 0.03 45.72 Hepatic cirrhosis | 2 0.02 45.74 Hepatic cyst | 1 0.01 45.75 Hepatic encephalopathy | 2 0.02 45.77 Hepatic enzyme increased | 12 0.12 45.89 Hepatic failure | 8 0.08 45.97 Hepatic function abnormal | 15 0.15 46.12 Hepatic mass | 1 0.01 46.13 Hepatic neoplasm | 1 0.01 46.14 Hepatic pain | 2 0.02 46.16 Hepatic steatosis | 1 0.01 46.17 Hepatitis | 5 0.05 46.22 Hepatitis B antigen positive | 1 0.01 46.23 Hepatitis C | 4 0.04 46.27 Hepatitis acute | 4 0.04 46.31 Hepatitis cholestatic | 1 0.01 46.32 Hepatobiliary disease | 3 0.03 46.35 Hepatocellular carcinoma | 2 0.02 46.37 Hepatocellular injury | 3 0.03 46.40 Hepatomegaly | 1 0.01 46.41 Hepatorenal failure | 1 0.01 46.42 Hepatotoxicity | 4 0.04 46.46 Hernia | 4 0.04 46.50 Hernia hiatus repair | 1 0.01 46.51 Hernia repair | 2 0.02 46.53 Herpes simplex | 4 0.04 46.57 Herpes virus infection | 2 0.02 46.59 Herpes zoster | 15 0.15 46.74 Herpes zoster oticus | 2 0.02 46.76 Hiatus hernia | 11 0.11 46.87 Hiccups | 1 0.01 46.88 High density lipoprotein decreased | 3 0.03 46.91 High risk pregnancy | 1 0.01 46.92 Hip arthroplasty | 7 0.07 46.99 Hip deformity | 1 0.01 47.00 Hip fracture | 15 0.15 47.15 Hip surgery | 3 0.03 47.18 Histiocytosis haematophagic | 4 0.04 47.22 Hodgkin's disease | 1 0.01 47.23 Homicidal ideation | 1 0.01 47.24 Homicide | 2 0.02 47.26 Hormone level abnormal | 4 0.04 47.30 Horner's syndrome | 1 0.01 47.31 Hospitalisation | 15 0.15 47.46 Hot flush | 10 0.10 47.56 Humerus fracture | 5 0.05 47.61 Hunger | 1 0.01 47.62 Hydrocephalus | 4 0.04 47.66 Hydronephrosis | 4 0.04 47.70 Hydroureter | 1 0.01 47.71 Hyperacusis | 1 0.01 47.72 Hyperammonaemia | 1 0.01 47.73 Hyperamylasaemia | 1 0.01 47.74 Hyperbilirubinaemia | 2 0.02 47.76 Hypercalcaemia | 4 0.04 47.80 Hypercapnia | 1 0.01 47.81 Hypercholesterolaemia | 19 0.19 48.00 Hypergammaglobulinaemia | 1 0.01 48.01 Hyperglycaemia | 17 0.17 48.18 Hyperhidrosis | 14 0.14 48.32 Hyperkalaemia | 5 0.05 48.37 Hyperkeratosis | 2 0.02 48.39 Hyperlipidaemia | 18 0.18 48.57 Hypernatraemia | 2 0.02 48.59 Hyperparathyroidism secondary | 1 0.01 48.60 Hyperprolactinaemia | 1 0.01 48.61 Hyperreflexia | 1 0.01 48.62 Hypersensitivity | 18 0.18 48.80 Hypersexuality | 2 0.02 48.82 Hypersomnia | 1 0.01 48.83 Hypertension | 76 0.76 49.59 Hypertensive crisis | 1 0.01 49.60 Hypertensive heart disease | 2 0.02 49.62 Hyperthermia | 2 0.02 49.64 Hypertonic bladder | 3 0.03 49.67 Hypertrichosis | 2 0.02 49.69 Hypertriglyceridaemia | 3 0.03 49.72 Hypertrophic cardiomyopathy | 1 0.01 49.73 Hypertrophy | 1 0.01 49.74 Hyperuricaemia | 3 0.03 49.77 Hyphaema | 1 0.01 49.78 Hypoacusis | 10 0.10 49.88 Hypoaesthesia | 23 0.23 50.11 Hypoaesthesia oral | 1 0.01 50.12 Hypoalbuminaemia | 6 0.06 50.18 Hypocalcaemia | 9 0.09 50.27 Hypogammaglobulinaemia | 1 0.01 50.28 Hypoglycaemia | 6 0.06 50.34 Hypoglycaemic unconsciousness | 1 0.01 50.35 Hypogonadism | 2 0.02 50.37 Hypokalaemia | 10 0.10 50.47 Hypokinesia | 3 0.03 50.50 Hypomagnesaemia | 6 0.06 50.56 Hyponatraemia | 10 0.10 50.66 Hypoparathyroidism secondary | 3 0.03 50.69 Hypophagia | 1 0.01 50.70 Hypophosphataemia | 5 0.05 50.75 Hypophysitis | 2 0.02 50.77 Hypopituitarism | 2 0.02 50.79 Hypopnoea | 1 0.01 50.80 Hypotelorism of orbit | 1 0.01 50.81 Hypotension | 22 0.22 51.03 Hypothermia | 2 0.02 51.05 Hypothyroidism | 22 0.22 51.27 Hypotonia | 4 0.04 51.31 Hypoventilation | 2 0.02 51.33 Hypovolaemia | 1 0.01 51.34 Hypovolaemic shock | 1 0.01 51.35 Hypoxia | 10 0.10 51.45 Hysterectomy | 9 0.09 51.54 Hysterosalpingo-oophorectomy | 2 0.02 51.56 Ileal stenosis | 1 0.01 51.57 Ileostomy closure | 1 0.01 51.58 Ileus | 8 0.08 51.66 Ileus paralytic | 1 0.01 51.67 Iliac artery occlusion | 1 0.01 51.68 Ill-defined disorder | 10 0.10 51.78 Immobile | 1 0.01 51.79 Immune reconstitution inflammatory sy.. | 2 0.02 51.81 Immune thrombocytopenic purpura | 2 0.02 51.83 Immunodeficiency | 2 0.02 51.85 Immunodeficiency common variable | 1 0.01 51.86 Immunosuppression | 2 0.02 51.88 Impaired driving ability | 4 0.04 51.92 Impaired gastric emptying | 1 0.01 51.93 Impaired healing | 16 0.16 52.09 Impaired quality of life | 2 0.02 52.11 Impaired work ability | 4 0.04 52.15 Implant site pain | 1 0.01 52.16 Impulse-control disorder | 3 0.03 52.19 Impulsive behaviour | 4 0.04 52.23 Inability to afford medication | 2 0.02 52.25 Inadequate analgesia | 1 0.01 52.26 Inappropriate schedule of drug admini.. | 17 0.17 52.43 Incision site cellulitis | 1 0.01 52.44 Incision site inflammation | 1 0.01 52.45 Incision site swelling | 1 0.01 52.46 Incisional drainage | 1 0.01 52.47 Incisional hernia | 1 0.01 52.48 Incontinence | 2 0.02 52.50 Incorrect dose administered | 5 0.05 52.55 Incorrect drug administration duration | 3 0.03 52.58 Incorrect route of drug administration | 6 0.06 52.64 Increased appetite | 1 0.01 52.65 Increased bronchial secretion | 1 0.01 52.66 Increased tendency to bruise | 5 0.05 52.71 Induration | 1 0.01 52.72 Infarction | 1 0.01 52.73 Infected skin ulcer | 1 0.01 52.74 Infection | 35 0.35 53.09 Infection susceptibility increased | 1 0.01 53.10 Infectious pleural effusion | 1 0.01 53.11 Infective pulmonary exacerbation of c.. | 2 0.02 53.13 Inferior vena cava syndrome | 1 0.01 53.14 Infertility | 1 0.01 53.15 Infertility female | 1 0.01 53.16 Inflammation | 7 0.07 53.23 Influenza | 20 0.20 53.43 Influenza like illness | 8 0.08 53.51 Infrequent bowel movements | 2 0.02 53.53 Infusion related reaction | 7 0.07 53.60 Infusion site erythema | 2 0.02 53.62 Infusion site pain | 1 0.01 53.63 Infusion site reaction | 1 0.01 53.64 Infusion site swelling | 1 0.01 53.65 Inguinal hernia | 2 0.02 53.67 Inguinal hernia repair | 2 0.02 53.69 Initial insomnia | 1 0.01 53.70 Injection site bruising | 6 0.06 53.76 Injection site discolouration | 1 0.01 53.77 Injection site erythema | 6 0.06 53.83 Injection site haematoma | 1 0.01 53.84 Injection site haemorrhage | 2 0.02 53.86 Injection site hypertrophy | 1 0.01 53.87 Injection site induration | 1 0.01 53.88 Injection site inflammation | 1 0.01 53.89 Injection site mass | 2 0.02 53.91 Injection site nodule | 1 0.01 53.92 Injection site pain | 12 0.12 54.04 Injection site pruritus | 1 0.01 54.05 Injection site rash | 1 0.01 54.06 Injection site reaction | 2 0.02 54.08 Injection site scab | 1 0.01 54.09 Injection site swelling | 3 0.03 54.12 Injection site urticaria | 1 0.01 54.13 Injection site warmth | 1 0.01 54.14 Injury | 13 0.13 54.27 Injury associated with device | 1 0.01 54.28 Insomnia | 44 0.44 54.72 Insulin resistance | 1 0.01 54.73 Insulin-like growth factor increased | 4 0.04 54.77 Insurance issue | 4 0.04 54.81 Intellectual disability | 2 0.02 54.83 Intensive care unit acquired weakness | 1 0.01 54.84 Intentional device misuse | 2 0.02 54.86 Intentional device use issue | 1 0.01 54.87 Intentional overdose | 6 0.06 54.93 Intentional product misuse | 24 0.24 55.17 Intentional product use issue | 10 0.10 55.27 Intentional self-injury | 1 0.01 55.28 Intentional underdose | 1 0.01 55.29 Intercostal neuralgia | 1 0.01 55.30 Intermittent claudication | 1 0.01 55.31 Internal fixation of fracture | 2 0.02 55.33 Internal haemorrhage | 2 0.02 55.35 International normalised ratio increa.. | 4 0.04 55.39 Interstitial lung disease | 28 0.28 55.67 Intervertebral disc compression | 1 0.01 55.68 Intervertebral disc degeneration | 11 0.11 55.79 Intervertebral disc disorder | 2 0.02 55.81 Intervertebral disc operation | 1 0.01 55.82 Intervertebral disc protrusion | 6 0.06 55.88 Intervertebral disc space narrowing | 1 0.01 55.89 Intestinal infarction | 1 0.01 55.90 Intestinal obstruction | 4 0.04 55.94 Intestinal perforation | 2 0.02 55.96 Intestinal resection | 2 0.02 55.98 Intra-abdominal haematoma | 1 0.01 55.99 Intracranial aneurysm | 1 0.01 56.00 Intracranial pressure increased | 2 0.02 56.02 Intracranial venous sinus thrombosis | 1 0.01 56.03 Intramedullary rod insertion | 26 0.26 56.29 Intraocular pressure increased | 1 0.01 56.30 Invasive ductal breast carcinoma | 1 0.01 56.31 Iris hypopigmentation | 1 0.01 56.32 Iris transillumination defect | 1 0.01 56.33 Iritis | 1 0.01 56.34 Iron deficiency | 1 0.01 56.35 Iron deficiency anaemia | 5 0.05 56.40 Iron overload | 1 0.01 56.41 Irritability | 2 0.02 56.43 Irritable bowel syndrome | 5 0.05 56.48 Ischaemia | 1 0.01 56.49 Ischaemic cardiomyopathy | 1 0.01 56.50 Ischaemic cerebral infarction | 2 0.02 56.52 Ischaemic stroke | 4 0.04 56.56 Jaundice | 4 0.04 56.60 Jaundice cholestatic | 1 0.01 56.61 Jaundice neonatal | 1 0.01 56.62 Jaw disorder | 4 0.04 56.66 Joint arthroplasty | 1 0.01 56.67 Joint contracture | 1 0.01 56.68 Joint crepitation | 1 0.01 56.69 Joint dislocation | 5 0.05 56.74 Joint effusion | 4 0.04 56.78 Joint hyperextension | 1 0.01 56.79 Joint injury | 9 0.09 56.88 Joint instability | 1 0.01 56.89 Joint range of motion decreased | 1 0.01 56.90 Joint stiffness | 3 0.03 56.93 Joint swelling | 18 0.18 57.11 Jugular vein thrombosis | 1 0.01 57.12 Keratomileusis | 1 0.01 57.13 Keratosis pilaris | 1 0.01 57.14 Ketosis | 1 0.01 57.15 Kidney fibrosis | 1 0.01 57.16 Kidney transplant rejection | 1 0.01 57.17 Klebsiella infection | 1 0.01 57.18 Klinefelter's syndrome | 1 0.01 57.19 Knee arthroplasty | 13 0.13 57.32 Knee deformity | 1 0.01 57.33 Knee operation | 2 0.02 57.35 Kyphoscoliosis | 2 0.02 57.37 Kyphosis | 7 0.07 57.44 Labelled drug-drug interaction medica.. | 1 0.01 57.45 Labyrinthitis | 1 0.01 57.46 Laceration | 3 0.03 57.49 Lacrimal duct procedure | 1 0.01 57.50 Lacrimation increased | 2 0.02 57.52 Lactate dehydrogenase urine increased | 1 0.01 57.53 Lactose intolerance | 1 0.01 57.54 Lacunar infarction | 1 0.01 57.55 Laparoscopy | 1 0.01 57.56 Large intestinal obstruction | 1 0.01 57.57 Large intestinal ulcer | 1 0.01 57.58 Large intestine perforation | 3 0.03 57.61 Large intestine polyp | 3 0.03 57.64 Laryngitis | 3 0.03 57.67 Latent tuberculosis | 1 0.01 57.68 Learning disability | 1 0.01 57.69 Learning disorder | 3 0.03 57.72 Left ventricular dysfunction | 3 0.03 57.75 Left ventricular failure | 3 0.03 57.78 Lens disorder | 1 0.01 57.79 Lethargy | 3 0.03 57.82 Leukaemia | 2 0.02 57.84 Leukaemia recurrent | 1 0.01 57.85 Leukocytosis | 2 0.02 57.87 Leukoencephalopathy | 1 0.01 57.88 Leukopenia | 14 0.14 58.02 Libido decreased | 4 0.04 58.06 Ligament injury | 1 0.01 58.07 Ligament operation | 1 0.01 58.08 Ligament rupture | 2 0.02 58.10 Ligament sprain | 10 0.10 58.20 Limb asymmetry | 1 0.01 58.21 Limb crushing injury | 1 0.01 58.22 Limb discomfort | 5 0.05 58.27 Limb injury | 9 0.09 58.36 Limb operation | 6 0.06 58.42 Linear IgA disease | 1 0.01 58.43 Lip disorder | 2 0.02 58.45 Lip swelling | 2 0.02 58.47 Lipase increased | 1 0.01 58.48 Lipids increased | 1 0.01 58.49 Liquid product physical issue | 1 0.01 58.50 Live birth | 1 0.01 58.51 Liver abscess | 1 0.01 58.52 Liver disorder | 7 0.07 58.59 Liver function test abnormal | 3 0.03 58.62 Liver function test increased | 6 0.06 58.68 Liver transplant | 1 0.01 58.69 Localised infection | 4 0.04 58.73 Lordosis | 1 0.01 58.74 Loss of consciousness | 16 0.16 58.90 Loss of employment | 1 0.01 58.91 Loss of libido | 2 0.02 58.93 Loss of personal independence in dail.. | 9 0.09 59.02 Low birth weight baby | 2 0.02 59.04 Low density lipoprotein decreased | 1 0.01 59.05 Low density lipoprotein increased | 2 0.02 59.07 Low set ears | 2 0.02 59.09 Low turnover osteopathy | 108 1.08 60.17 Lower limb fracture | 7 0.07 60.24 Lower respiratory tract infection | 2 0.02 60.26 Ludwig angina | 1 0.01 60.27 Lumbar radiculopathy | 2 0.02 60.29 Lumbar spinal stenosis | 10 0.10 60.39 Lumbar vertebral fracture | 9 0.09 60.48 Lumbosacral radiculopathy | 1 0.01 60.49 Lung adenocarcinoma | 2 0.02 60.51 Lung carcinoma cell type unspecified .. | 2 0.02 60.53 Lung disorder | 15 0.15 60.68 Lung hyperinflation | 1 0.01 60.69 Lung infection | 9 0.09 60.78 Lung infiltration | 2 0.02 60.80 Lung neoplasm | 1 0.01 60.81 Lung neoplasm malignant | 5 0.05 60.86 Lupus nephritis | 5 0.05 60.91 Lupus-like syndrome | 1 0.01 60.92 Luteal phase deficiency | 1 0.01 60.93 Lymph node pain | 1 0.01 60.94 Lymphadenitis | 2 0.02 60.96 Lymphadenopathy | 7 0.07 61.03 Lymphangiopathy | 1 0.01 61.04 Lymphocyte count | 1 0.01 61.05 Lymphocyte count decreased | 4 0.04 61.09 Lymphoedema | 1 0.01 61.10 Lymphoma | 2 0.02 61.12 Lymphopenia | 6 0.06 61.18 Lymphoproliferative disorder | 1 0.01 61.19 Macrocephaly | 1 0.01 61.20 Macrocytosis | 1 0.01 61.21 Macular degeneration | 2 0.02 61.23 Macular detachment | 1 0.01 61.24 Maculopathy | 1 0.01 61.25 Major depression | 2 0.02 61.27 Malabsorption | 1 0.01 61.28 Malaise | 64 0.64 61.92 Malaria | 1 0.01 61.93 Malignant hypertension | 1 0.01 61.94 Malignant melanoma | 3 0.03 61.97 Malignant melanoma in situ | 1 0.01 61.98 Malignant neoplasm progression | 35 0.35 62.33 Malignant pleural effusion | 1 0.01 62.34 Malnutrition | 4 0.04 62.38 Malpositioned teeth | 1 0.01 62.39 Mania | 5 0.05 62.44 Marital problem | 1 0.01 62.45 Mass | 2 0.02 62.47 Mastectomy | 1 0.01 62.48 Mastoiditis | 1 0.01 62.49 Maternal exposure during pregnancy | 18 0.18 62.67 Maternal exposure timing unspecified | 2 0.02 62.69 Mean cell haemoglobin increased | 1 0.01 62.70 Mean cell volume abnormal | 1 0.01 62.71 Mean platelet volume increased | 1 0.01 62.72 Medical device pain | 1 0.01 62.73 Medical device removal | 8 0.08 62.81 Medication error | 2 0.02 62.83 Melaena | 2 0.02 62.85 Melanocytic naevus | 1 0.01 62.86 Memory impairment | 26 0.26 63.12 Meniere's disease | 1 0.01 63.13 Meningism | 1 0.01 63.14 Meningitis | 1 0.01 63.15 Meningitis bacterial | 1 0.01 63.16 Meningitis viral | 1 0.01 63.17 Meningococcal sepsis | 1 0.01 63.18 Meningoencephalitis herpetic | 1 0.01 63.19 Meniscus injury | 4 0.04 63.23 Menopausal symptoms | 2 0.02 63.25 Menorrhagia | 2 0.02 63.27 Menstrual disorder | 2 0.02 63.29 Menstruation irregular | 1 0.01 63.30 Mental disorder | 6 0.06 63.36 Mental impairment | 3 0.03 63.39 Mental status changes | 5 0.05 63.44 Meralgia paraesthetica | 2 0.02 63.46 Metabolic acidosis | 4 0.04 63.50 Metabolic disorder | 1 0.01 63.51 Metabolic encephalopathy | 3 0.03 63.54 Metabolic syndrome | 1 0.01 63.55 Metastases to bone | 3 0.03 63.58 Metastases to central nervous system | 1 0.01 63.59 Metastases to liver | 6 0.06 63.65 Metastases to lung | 3 0.03 63.68 Metastatic malignant melanoma | 1 0.01 63.69 Methaemoglobinaemia | 1 0.01 63.70 Metrorrhagia | 1 0.01 63.71 Microcephaly | 1 0.01 63.72 Micturition urgency | 4 0.04 63.76 Middle insomnia | 5 0.05 63.81 Migraine | 7 0.07 63.88 Migraine with aura | 1 0.01 63.89 Miosis | 1 0.01 63.90 Mite allergy | 1 0.01 63.91 Mitochondrial DNA mutation | 1 0.01 63.92 Mitral valve disease | 2 0.02 63.94 Mitral valve disease mixed | 1 0.01 63.95 Mitral valve incompetence | 1 0.01 63.96 Mitral valve prolapse | 1 0.01 63.97 Moaning | 1 0.01 63.98 Mobility decreased | 7 0.07 64.05 Molluscum contagiosum | 1 0.01 64.06 Monocyte count decreased | 1 0.01 64.07 Monocyte count increased | 2 0.02 64.09 Mononucleosis syndrome | 1 0.01 64.10 Monoplegia | 1 0.01 64.11 Mood altered | 3 0.03 64.14 Mood disorder due to a general medica.. | 1 0.01 64.15 Moraxella infection | 1 0.01 64.16 Morton's neuralgia | 1 0.01 64.17 Motor developmental delay | 1 0.01 64.18 Motor dysfunction | 3 0.03 64.21 Mouth ulceration | 6 0.06 64.27 Movement disorder | 4 0.04 64.31 Mucosal inflammation | 9 0.09 64.40 Mucosal ulceration | 1 0.01 64.41 Multiple allergies | 5 0.05 64.46 Multiple congenital abnormalities | 2 0.02 64.48 Multiple fractures | 2 0.02 64.50 Multiple organ dysfunction syndrome | 16 0.16 64.66 Multiple sclerosis | 5 0.05 64.71 Multiple sclerosis relapse | 12 0.12 64.83 Muscle contractions involuntary | 1 0.01 64.84 Muscle fibrosis | 1 0.01 64.85 Muscle injury | 2 0.02 64.87 Muscle rigidity | 1 0.01 64.88 Muscle rupture | 1 0.01 64.89 Muscle spasms | 23 0.23 65.12 Muscle spasticity | 2 0.02 65.14 Muscle strain | 4 0.04 65.18 Muscle tone disorder | 1 0.01 65.19 Muscle twitching | 2 0.02 65.21 Muscular weakness | 24 0.24 65.45 Musculoskeletal chest pain | 2 0.02 65.47 Musculoskeletal discomfort | 3 0.03 65.50 Musculoskeletal disorder | 3 0.03 65.53 Musculoskeletal pain | 13 0.13 65.66 Musculoskeletal stiffness | 15 0.15 65.81 Myalgia | 21 0.21 66.02 Myasthenia gravis | 2 0.02 66.04 Mydriasis | 1 0.01 66.05 Myelodysplastic syndrome | 2 0.02 66.07 Myeloproliferative neoplasm | 1 0.01 66.08 Myocardial infarction | 22 0.22 66.30 Myocardial ischaemia | 4 0.04 66.34 Myocarditis | 2 0.02 66.36 Myoglobin blood increased | 1 0.01 66.37 Myoglobinuria | 1 0.01 66.38 Myopathy | 4 0.04 66.42 Myopia | 2 0.02 66.44 Myositis | 1 0.01 66.45 Nail bed bleeding | 1 0.01 66.46 Nail discolouration | 1 0.01 66.47 Nail disorder | 2 0.02 66.49 Nail dystrophy | 1 0.01 66.50 Nail growth abnormal | 1 0.01 66.51 Nail hypertrophy | 1 0.01 66.52 Narcolepsy | 1 0.01 66.53 Nasal congestion | 4 0.04 66.57 Nasal discharge discolouration | 1 0.01 66.58 Nasal obstruction | 1 0.01 66.59 Nasal polyps | 1 0.01 66.60 Nasopharyngitis | 34 0.34 66.94 Nausea | 58 0.58 67.52 Neck injury | 1 0.01 67.53 Neck mass | 1 0.01 67.54 Neck pain | 11 0.11 67.65 Neck surgery | 1 0.01 67.66 Needle issue | 1 0.01 67.67 Negative thoughts | 1 0.01 67.68 Neonatal hypoxia | 1 0.01 67.69 Neonatal respiratory arrest | 1 0.01 67.70 Neoplasm | 4 0.04 67.74 Neoplasm malignant | 8 0.08 67.82 Neoplasm progression | 10 0.10 67.92 Neovascular age-related macular degen.. | 1 0.01 67.93 Nephritis | 1 0.01 67.94 Nephrogenic diabetes insipidus | 1 0.01 67.95 Nephrolithiasis | 8 0.08 68.03 Nephropathy | 1 0.01 68.04 Nephropathy toxic | 1 0.01 68.05 Nephrotic syndrome | 1 0.01 68.06 Nerve block | 1 0.01 68.07 Nerve compression | 4 0.04 68.11 Nerve injury | 2 0.02 68.13 Nervous system disorder | 4 0.04 68.17 Nervousness | 4 0.04 68.21 Neuralgia | 3 0.03 68.24 Neuritis | 1 0.01 68.25 Neuritis cranial | 1 0.01 68.26 Neurodermatitis | 1 0.01 68.27 Neuroma | 1 0.01 68.28 Neuropathy peripheral | 14 0.14 68.42 Neurosis | 1 0.01 68.43 Neurotoxicity | 3 0.03 68.46 Neutropenia | 31 0.31 68.77 Neutropenic colitis | 1 0.01 68.78 Neutropenic infection | 1 0.01 68.79 Neutropenic sepsis | 4 0.04 68.83 Neutrophil count abnormal | 1 0.01 68.84 Neutrophil count decreased | 16 0.16 69.00 Neutrophil count increased | 2 0.02 69.02 Night sweats | 3 0.03 69.05 Nightmare | 2 0.02 69.07 Nipple disorder | 1 0.01 69.08 No adverse event | 1 0.01 69.09 Nocturia | 3 0.03 69.12 Nodal osteoarthritis | 1 0.01 69.13 Nodule | 4 0.04 69.17 Non-Hodgkin's lymphoma | 2 0.02 69.19 Non-cardiac chest pain | 2 0.02 69.21 Non-small cell lung cancer | 1 0.01 69.22 Noninfective gingivitis | 1 0.01 69.23 Normal pressure hydrocephalus | 1 0.01 69.24 Nuclear magnetic resonance imaging ab.. | 2 0.02 69.26 Nystagmus | 2 0.02 69.28 Obesity | 1 0.01 69.29 Obsessive thoughts | 1 0.01 69.30 Obstructive airways disorder | 6 0.06 69.36 Obstructive pancreatitis | 1 0.01 69.37 Occult blood positive | 1 0.01 69.38 Ocular hyperaemia | 1 0.01 69.39 Ocular icterus | 2 0.02 69.41 Ocular myasthenia | 1 0.01 69.42 Ocular vascular disorder | 1 0.01 69.43 Oculogyric crisis | 3 0.03 69.46 Odynophagia | 1 0.01 69.47 Oedema | 5 0.05 69.52 Oedema peripheral | 24 0.24 69.76 Oedematous pancreatitis | 1 0.01 69.77 Oesophageal carcinoma | 1 0.01 69.78 Oesophageal disorder | 1 0.01 69.79 Oesophageal haemorrhage | 1 0.01 69.80 Oesophageal irritation | 1 0.01 69.81 Oesophageal varices haemorrhage | 1 0.01 69.82 Oesophagitis | 5 0.05 69.87 Oestradiol increased | 1 0.01 69.88 Oestrogen deficiency | 3 0.03 69.91 Off label use | 81 0.81 70.72 Oligodendroglioma | 2 0.02 70.74 Onychoclasis | 2 0.02 70.76 Onychomycosis | 5 0.05 70.81 Open reduction of fracture | 11 0.11 70.92 Ophthalmic herpes simplex | 1 0.01 70.93 Ophthalmic vein thrombosis | 1 0.01 70.94 Optic atrophy | 1 0.01 70.95 Optic ischaemic neuropathy | 1 0.01 70.96 Optic neuritis | 2 0.02 70.98 Oral candidiasis | 3 0.03 71.01 Oral discomfort | 1 0.01 71.02 Oral herpes | 4 0.04 71.06 Oral infection | 1 0.01 71.07 Oral mucosal blistering | 1 0.01 71.08 Oral pain | 2 0.02 71.10 Oral surgery | 2 0.02 71.12 Organ failure | 1 0.01 71.13 Organising pneumonia | 2 0.02 71.15 Oromandibular dystonia | 1 0.01 71.16 Oropharyngeal pain | 8 0.08 71.24 Orthostatic hypotension | 2 0.02 71.26 Ostectomy | 1 0.01 71.27 Osteoarthritis | 55 0.55 71.82 Osteochondrosis | 1 0.01 71.83 Osteogenesis imperfecta | 1 0.01 71.84 Osteoma | 1 0.01 71.85 Osteomyelitis | 5 0.05 71.90 Osteonecrosis | 4 0.04 71.94 Osteonecrosis of jaw | 8 0.08 72.02 Osteopenia | 17 0.17 72.19 Osteoporosis | 38 0.38 72.57 Osteosclerosis | 1 0.01 72.58 Otitis media | 1 0.01 72.59 Otitis media acute | 1 0.01 72.60 Otorrhoea | 1 0.01 72.61 Ovarian calcification | 1 0.01 72.62 Ovarian cyst | 2 0.02 72.64 Ovarian cystectomy | 1 0.01 72.65 Ovarian failure | 1 0.01 72.66 Ovarian mass | 1 0.01 72.67 Overdose | 20 0.20 72.87 Overweight | 1 0.01 72.88 Oxygen saturation decreased | 6 0.06 72.94 Oxygen saturation increased | 1 0.01 72.95 Oxygen therapy | 1 0.01 72.96 PCO2 decreased | 1 0.01 72.97 PO2 increased | 1 0.01 72.98 Packed red blood cell transfusion | 2 0.02 73.00 Pain | 72 0.72 73.72 Pain in extremity | 64 0.64 74.36 Pain in jaw | 4 0.04 74.40 Pain of skin | 4 0.04 74.44 Painful respiration | 1 0.01 74.45 Pallor | 4 0.04 74.49 Palmar-plantar erythrodysaesthesia sy.. | 6 0.06 74.55 Palpitations | 14 0.14 74.69 Pancreatic carcinoma | 3 0.03 74.72 Pancreatic enzymes abnormal | 1 0.01 74.73 Pancreatic neoplasm | 1 0.01 74.74 Pancreatitis | 3 0.03 74.77 Pancreatitis acute | 5 0.05 74.82 Pancreatitis necrotising | 1 0.01 74.83 Pancytopenia | 10 0.10 74.93 Panic attack | 11 0.11 75.04 Panniculitis | 1 0.01 75.05 Papillary thyroid cancer | 1 0.01 75.06 Papilloedema | 2 0.02 75.08 Papilloma | 1 0.01 75.09 Papule | 1 0.01 75.10 Paraesthesia | 22 0.22 75.32 Paranasal sinus hypersecretion | 1 0.01 75.33 Paranoia | 8 0.08 75.41 Paraphilia | 1 0.01 75.42 Parkinson's disease | 3 0.03 75.45 Parkinsonism | 2 0.02 75.47 Partial seizures | 1 0.01 75.48 Patella fracture | 5 0.05 75.53 Patellofemoral pain syndrome | 2 0.02 75.55 Paternal exposure timing unspecified | 2 0.02 75.57 Pathogen resistance | 2 0.02 75.59 Pathological fracture | 6 0.06 75.65 Pelvic abscess | 1 0.01 75.66 Pelvic floor muscle weakness | 1 0.01 75.67 Pelvic fracture | 5 0.05 75.72 Pelvic pain | 3 0.03 75.75 Pelvic prolapse | 1 0.01 75.76 Penile pain | 1 0.01 75.77 Peptic ulcer | 3 0.03 75.80 Pericardial effusion | 2 0.02 75.82 Pericarditis | 3 0.03 75.85 Perineal pain | 1 0.01 75.86 Periodontal operation | 1 0.01 75.87 Periodontitis | 2 0.02 75.89 Periorbital haemorrhage | 1 0.01 75.90 Periorbital oedema | 1 0.01 75.91 Peripheral arterial occlusive disease | 1 0.01 75.92 Peripheral motor neuropathy | 1 0.01 75.93 Peripheral nerve injury | 1 0.01 75.94 Peripheral sensory neuropathy | 4 0.04 75.98 Peripheral swelling | 20 0.20 76.18 Peripheral vascular disorder | 5 0.05 76.23 Peripheral venous disease | 4 0.04 76.27 Peritoneal perforation | 1 0.01 76.28 Peritonitis | 2 0.02 76.30 Peritonitis bacterial | 1 0.01 76.31 Persecutory delusion | 1 0.01 76.32 Personality change | 2 0.02 76.34 Personality disorder | 2 0.02 76.36 Petechiae | 1 0.01 76.37 Peyronie's disease | 1 0.01 76.38 Pharyngeal disorder | 2 0.02 76.40 Pharyngeal erosion | 1 0.01 76.41 Pharyngitis | 5 0.05 76.46 Phimosis | 1 0.01 76.47 Phlebitis | 1 0.01 76.48 Photophobia | 3 0.03 76.51 Photopsia | 1 0.01 76.52 Photosensitivity reaction | 1 0.01 76.53 Physical assault | 2 0.02 76.55 Physical disability | 1 0.01 76.56 Pickwickian syndrome | 1 0.01 76.57 Pituitary tumour benign | 1 0.01 76.58 Pityriasis | 1 0.01 76.59 Plagiocephaly | 1 0.01 76.60 Plantar fascial fibromatosis | 1 0.01 76.61 Plantar fasciitis | 3 0.03 76.64 Plasma cell myeloma | 4 0.04 76.68 Platelet count decreased | 25 0.25 76.93 Platelet count increased | 1 0.01 76.94 Pleural effusion | 16 0.16 77.10 Pleural fibrosis | 1 0.01 77.11 Pleurisy | 3 0.03 77.14 Pleuritic pain | 1 0.01 77.15 Pneumatosis intestinalis | 1 0.01 77.16 Pneumococcal sepsis | 2 0.02 77.18 Pneumocystis jirovecii pneumonia | 4 0.04 77.22 Pneumonectomy | 1 0.01 77.23 Pneumonia | 67 0.67 77.90 Pneumonia aspiration | 1 0.01 77.91 Pneumonia bacterial | 4 0.04 77.95 Pneumonia fungal | 1 0.01 77.96 Pneumonia mycoplasmal | 2 0.02 77.98 Pneumonia pneumococcal | 1 0.01 77.99 Pneumonia staphylococcal | 2 0.02 78.01 Pneumonia viral | 1 0.01 78.02 Pneumonitis | 8 0.08 78.10 Pneumoperitoneum | 2 0.02 78.12 Pneumothorax | 4 0.04 78.16 Pollakiuria | 7 0.07 78.23 Polyarthritis | 2 0.02 78.25 Polycythaemia | 1 0.01 78.26 Polymenorrhoea | 1 0.01 78.27 Polymyalgia rheumatica | 3 0.03 78.30 Polymyositis | 1 0.01 78.31 Polyneuropathy | 4 0.04 78.35 Polyomavirus-associated nephropathy | 3 0.03 78.38 Polyp | 1 0.01 78.39 Polyuria | 2 0.02 78.41 Poor feeding infant | 1 0.01 78.42 Poor peripheral circulation | 1 0.01 78.43 Poor quality drug administered | 2 0.02 78.45 Poor quality sleep | 4 0.04 78.49 Post herpetic neuralgia | 1 0.01 78.50 Post inflammatory pigmentation change | 1 0.01 78.51 Post procedural complication | 3 0.03 78.54 Post procedural constipation | 1 0.01 78.55 Post procedural haemorrhage | 3 0.03 78.58 Post procedural infection | 2 0.02 78.60 Post-traumatic stress disorder | 2 0.02 78.62 Postmenopausal haemorrhage | 2 0.02 78.64 Postoperative wound infection | 3 0.03 78.67 Postrenal failure | 1 0.01 78.68 Posture abnormal | 2 0.02 78.70 Potentiating drug interaction | 2 0.02 78.72 Pre-eclampsia | 2 0.02 78.74 Precancerous skin lesion | 1 0.01 78.75 Pregnancy with contraceptive device | 1 0.01 78.76 Premature baby | 2 0.02 78.78 Premature labour | 1 0.01 78.79 Prescribed overdose | 2 0.02 78.81 Prescribed underdose | 1 0.01 78.82 Presyncope | 7 0.07 78.89 Primary hypothyroidism | 1 0.01 78.90 Procedural complication | 1 0.01 78.91 Procedural nausea | 2 0.02 78.93 Procedural pain | 5 0.05 78.98 Procedural vomiting | 1 0.01 78.99 Proctalgia | 2 0.02 79.01 Proctitis | 1 0.01 79.02 Product adhesion issue | 3 0.03 79.05 Product colour issue | 1 0.01 79.06 Product packaging quantity issue | 1 0.01 79.07 Product physical issue | 1 0.01 79.08 Product quality issue | 11 0.11 79.19 Product storage error | 3 0.03 79.22 Product substitution issue | 3 0.03 79.25 Product taste abnormal | 1 0.01 79.26 Product use in unapproved indication | 33 0.33 79.59 Product use issue | 14 0.14 79.73 Productive cough | 7 0.07 79.80 Progesterone decreased | 1 0.01 79.81 Progressive multifocal leukoencephalo.. | 1 0.01 79.82 Propofol infusion syndrome | 1 0.01 79.83 Prostate cancer | 3 0.03 79.86 Prostate cancer recurrent | 2 0.02 79.88 Prostatic mass | 1 0.01 79.89 Prostatic specific antigen increased | 2 0.02 79.91 Prostatitis | 1 0.01 79.92 Protein total decreased | 2 0.02 79.94 Protein total increased | 1 0.01 79.95 Protein urine | 1 0.01 79.96 Proteinuria | 3 0.03 79.99 Pruritus | 23 0.23 80.22 Pruritus generalised | 1 0.01 80.23 Pruritus genital | 1 0.01 80.24 Pseudarthrosis | 2 0.02 80.26 Pseudocirrhosis | 1 0.01 80.27 Pseudomembranous colitis | 1 0.01 80.28 Pseudomonas infection | 1 0.01 80.29 Psoriasis | 8 0.08 80.37 Psoriatic arthropathy | 1 0.01 80.38 Psychiatric decompensation | 5 0.05 80.43 Psychiatric symptom | 8 0.08 80.51 Psychomotor hyperactivity | 3 0.03 80.54 Psychomotor retardation | 2 0.02 80.56 Psychotic behaviour | 2 0.02 80.58 Psychotic disorder | 17 0.17 80.75 Psychotic symptom | 2 0.02 80.77 Pubis fracture | 5 0.05 80.82 Pulmonary arterial hypertension | 3 0.03 80.85 Pulmonary artery aneurysm | 1 0.01 80.86 Pulmonary cavitation | 1 0.01 80.87 Pulmonary congestion | 4 0.04 80.91 Pulmonary embolism | 18 0.18 81.09 Pulmonary fibrosis | 2 0.02 81.11 Pulmonary function test abnormal | 1 0.01 81.12 Pulmonary granuloma | 2 0.02 81.14 Pulmonary haemorrhage | 3 0.03 81.17 Pulmonary hypertension | 6 0.06 81.23 Pulmonary mass | 3 0.03 81.26 Pulmonary mycosis | 1 0.01 81.27 Pulmonary oedema | 6 0.06 81.33 Pulmonary physical examination abnormal | 1 0.01 81.34 Pulmonary sequestration | 1 0.01 81.35 Pulmonary thrombosis | 3 0.03 81.38 Pulmonary toxicity | 2 0.02 81.40 Pulmonary vein stenosis | 1 0.01 81.41 Pulpitis dental | 1 0.01 81.42 Pulseless electrical activity | 1 0.01 81.43 Purulence | 1 0.01 81.44 Purulent discharge | 2 0.02 81.46 Pustular psoriasis | 1 0.01 81.47 Pyelonephritis | 4 0.04 81.51 Pyrexia | 63 0.63 82.14 Quadriplegia | 1 0.01 82.15 Radiation skin injury | 1 0.01 82.16 Radiculopathy | 3 0.03 82.19 Radiotherapy | 3 0.03 82.22 Radiotherapy to breast | 2 0.02 82.24 Radius fracture | 15 0.15 82.39 Rash | 36 0.36 82.75 Rash erythematous | 3 0.03 82.78 Rash generalised | 4 0.04 82.82 Rash maculo-papular | 2 0.02 82.84 Rash papular | 1 0.01 82.85 Rash pruritic | 1 0.01 82.86 Rebound effect | 1 0.01 82.87 Rectal abscess | 1 0.01 82.88 Rectal haemorrhage | 9 0.09 82.97 Rectal polyp | 2 0.02 82.99 Rectal tenesmus | 1 0.01 83.00 Rectocele | 3 0.03 83.03 Recurrent cancer | 1 0.01 83.04 Red blood cell abnormality | 1 0.01 83.05 Red blood cell count decreased | 5 0.05 83.10 Red blood cell count increased | 1 0.01 83.11 Red blood cell sedimentation rate abn.. | 1 0.01 83.12 Red blood cell sedimentation rate inc.. | 3 0.03 83.15 Red cell distribution width increased | 1 0.01 83.16 Red man syndrome | 1 0.01 83.17 Reflexes abnormal | 1 0.01 83.18 Reflux laryngitis | 1 0.01 83.19 Refractory anaemia with an excess of .. | 1 0.01 83.20 Regurgitation | 1 0.01 83.21 Removal of internal fixation | 3 0.03 83.24 Renal artery occlusion | 1 0.01 83.25 Renal artery stenosis | 1 0.01 83.26 Renal cyst | 3 0.03 83.29 Renal disorder | 12 0.12 83.41 Renal failure | 27 0.27 83.68 Renal impairment | 20 0.20 83.88 Renal malposition | 1 0.01 83.89 Renal neoplasm | 1 0.01 83.90 Renal scan abnormal | 1 0.01 83.91 Renal tubular atrophy | 1 0.01 83.92 Renal tubular necrosis | 3 0.03 83.95 Reocclusion | 1 0.01 83.96 Repetitive strain injury | 2 0.02 83.98 Resorption bone increased | 1 0.01 83.99 Respiratory arrest | 3 0.03 84.02 Respiratory disorder | 7 0.07 84.09 Respiratory distress | 2 0.02 84.11 Respiratory failure | 16 0.16 84.27 Respiratory paralysis | 1 0.01 84.28 Respiratory rate increased | 1 0.01 84.29 Respiratory tract congestion | 2 0.02 84.31 Respiratory tract infection | 2 0.02 84.33 Respiratory tract infection viral | 1 0.01 84.34 Restless legs syndrome | 5 0.05 84.39 Restlessness | 4 0.04 84.43 Restrictive pulmonary disease | 1 0.01 84.44 Retching | 2 0.02 84.46 Retinal detachment | 5 0.05 84.51 Retinal exudates | 1 0.01 84.52 Retinal haemorrhage | 1 0.01 84.53 Retinal operation | 1 0.01 84.54 Retinal pigment epitheliopathy | 1 0.01 84.55 Retinal tear | 2 0.02 84.57 Retinopathy hypertensive | 1 0.01 84.58 Retroperitoneal fibrosis | 1 0.01 84.59 Retroperitoneal haematoma | 2 0.02 84.61 Retroperitoneal haemorrhage | 1 0.01 84.62 Retroperitoneal lymphadenopathy | 1 0.01 84.63 Reversible ischaemic neurological def.. | 1 0.01 84.64 Rhabdomyolysis | 9 0.09 84.73 Rheumatic disorder | 1 0.01 84.74 Rheumatoid arthritis | 27 0.27 85.01 Rheumatoid nodule | 1 0.01 85.02 Rhinitis | 3 0.03 85.05 Rhinitis allergic | 3 0.03 85.08 Rhinitis perennial | 3 0.03 85.11 Rhinorrhoea | 9 0.09 85.20 Rib fracture | 16 0.16 85.36 Right ventricular failure | 3 0.03 85.39 Right ventricular hypertrophy | 1 0.01 85.40 Road traffic accident | 12 0.12 85.52 Rosacea | 2 0.02 85.54 Rotator cuff repair | 4 0.04 85.58 Rotator cuff syndrome | 9 0.09 85.67 Sacral hypoplasia | 1 0.01 85.68 Sacroiliitis | 1 0.01 85.69 Salivary hypersecretion | 2 0.02 85.71 Sarcoidosis | 1 0.01 85.72 Sarcoma | 1 0.01 85.73 Scab | 1 0.01 85.74 Scan myocardial perfusion abnormal | 1 0.01 85.75 Scar | 2 0.02 85.77 Scarlet fever | 1 0.01 85.78 Schizoaffective disorder | 3 0.03 85.81 Schizophrenia | 7 0.07 85.88 Sciatica | 10 0.10 85.98 Scleroderma-like reaction | 1 0.01 85.99 Scoliosis | 11 0.11 86.10 Scratch | 2 0.02 86.12 Screaming | 1 0.01 86.13 Scrotal pain | 1 0.01 86.14 Scrotal ulcer | 1 0.01 86.15 Seasonal allergy | 5 0.05 86.20 Seborrhoeic keratosis | 3 0.03 86.23 Second primary malignancy | 2 0.02 86.25 Sedation | 2 0.02 86.27 Seizure | 15 0.15 86.42 Self-injurious ideation | 1 0.01 86.43 Semen analysis abnormal | 1 0.01 86.44 Senile osteoporosis | 1 0.01 86.45 Sensitivity to weather change | 1 0.01 86.46 Sensory disturbance | 3 0.03 86.49 Sensory loss | 4 0.04 86.53 Sepsis | 34 0.34 86.87 Septic arthritis staphylococcal | 1 0.01 86.88 Septic embolus | 2 0.02 86.90 Septic necrosis | 1 0.01 86.91 Septic shock | 12 0.12 87.03 Seroma | 1 0.01 87.04 Seronegative arthritis | 1 0.01 87.05 Serotonin syndrome | 2 0.02 87.07 Serratia sepsis | 1 0.01 87.08 Serratia test positive | 1 0.01 87.09 Serum ferritin increased | 2 0.02 87.11 Serum sickness | 1 0.01 87.12 Sex hormone binding globulin increased | 1 0.01 87.13 Sexual dysfunction | 5 0.05 87.18 Shock | 11 0.11 87.29 Shock haemorrhagic | 3 0.03 87.32 Short-bowel syndrome | 1 0.01 87.33 Shoulder arthroplasty | 1 0.01 87.34 Shrinking lung syndrome | 1 0.01 87.35 Sialoadenitis | 2 0.02 87.37 Sickle cell anaemia with crisis | 1 0.01 87.38 Sinus bradycardia | 3 0.03 87.41 Sinus congestion | 2 0.02 87.43 Sinus disorder | 4 0.04 87.47 Sinus node dysfunction | 1 0.01 87.48 Sinus pain | 1 0.01 87.49 Sinus tachycardia | 5 0.05 87.54 Sinusitis | 11 0.11 87.65 Sjogren's syndrome | 1 0.01 87.66 Skin abrasion | 5 0.05 87.71 Skin burning sensation | 2 0.02 87.73 Skin cancer | 4 0.04 87.77 Skin candida | 1 0.01 87.78 Skin discolouration | 3 0.03 87.81 Skin disorder | 7 0.07 87.88 Skin erosion | 1 0.01 87.89 Skin exfoliation | 5 0.05 87.94 Skin fissures | 1 0.01 87.95 Skin hyperpigmentation | 1 0.01 87.96 Skin infection | 1 0.01 87.97 Skin irritation | 1 0.01 87.98 Skin lesion | 3 0.03 88.01 Skin mass | 2 0.02 88.03 Skin necrosis | 1 0.01 88.04 Skin neoplasm excision | 1 0.01 88.05 Skin odour abnormal | 1 0.01 88.06 Skin plaque | 1 0.01 88.07 Skin reaction | 1 0.01 88.08 Skin sensitisation | 1 0.01 88.09 Skin test positive | 1 0.01 88.10 Skin tightness | 1 0.01 88.11 Skin toxicity | 2 0.02 88.13 Skin ulcer | 11 0.11 88.24 Skull malformation | 1 0.01 88.25 Sleep apnoea syndrome | 9 0.09 88.34 Sleep disorder | 18 0.18 88.52 Sleep disorder due to a general medic.. | 1 0.01 88.53 Slow response to stimuli | 1 0.01 88.54 Small cell carcinoma | 1 0.01 88.55 Small cell lung cancer | 1 0.01 88.56 Small for dates baby | 1 0.01 88.57 Small intestinal haemorrhage | 1 0.01 88.58 Small intestinal obstruction | 1 0.01 88.59 Small intestinal perforation | 1 0.01 88.60 Small intestinal stenosis | 1 0.01 88.61 Sneezing | 4 0.04 88.65 Snoring | 2 0.02 88.67 Social problem | 3 0.03 88.70 Soft tissue disorder | 1 0.01 88.71 Soft tissue infection | 1 0.01 88.72 Soft tissue inflammation | 2 0.02 88.74 Soft tissue injury | 1 0.01 88.75 Soft tissue mass | 1 0.01 88.76 Somnambulism | 1 0.01 88.77 Somnolence | 21 0.21 88.98 Sopor | 3 0.03 89.01 Speech disorder | 9 0.09 89.10 Speech disorder developmental | 3 0.03 89.13 Spinal claudication | 2 0.02 89.15 Spinal column injury | 2 0.02 89.17 Spinal column stenosis | 2 0.02 89.19 Spinal compression fracture | 11 0.11 89.30 Spinal cord disorder | 1 0.01 89.31 Spinal disorder | 5 0.05 89.36 Spinal flattening | 2 0.02 89.38 Spinal fracture | 7 0.07 89.45 Spinal fusion surgery | 5 0.05 89.50 Spinal laminectomy | 2 0.02 89.52 Spinal operation | 3 0.03 89.55 Spinal osteoarthritis | 16 0.16 89.71 Spinal pain | 2 0.02 89.73 Spine malformation | 1 0.01 89.74 Splenectomy | 1 0.01 89.75 Splenic neoplasm malignancy unspecified | 1 0.01 89.76 Splenic vein thrombosis | 1 0.01 89.77 Spondylitis | 2 0.02 89.79 Spondylolisthesis | 5 0.05 89.84 Sputum discoloured | 3 0.03 89.87 Squamous cell carcinoma | 2 0.02 89.89 Staphylococcal bacteraemia | 2 0.02 89.91 Staphylococcal infection | 6 0.06 89.97 Staphylococcal sepsis | 1 0.01 89.98 Staphylococcus test positive | 1 0.01 89.99 Staring | 1 0.01 90.00 Starvation | 1 0.01 90.01 Stasis dermatitis | 1 0.01 90.02 Status epilepticus | 3 0.03 90.05 Stent placement | 1 0.01 90.06 Stereotypy | 1 0.01 90.07 Sternal fracture | 1 0.01 90.08 Steroid therapy | 1 0.01 90.09 Stevens-Johnson syndrome | 1 0.01 90.10 Stillbirth | 1 0.01 90.11 Stomatitis | 29 0.29 90.40 Strabismus | 1 0.01 90.41 Streptococcal infection | 2 0.02 90.43 Stress | 18 0.18 90.61 Stress fracture | 53 0.53 91.14 Stress urinary incontinence | 3 0.03 91.17 Stridor | 1 0.01 91.18 Subacute cutaneous lupus erythematosus | 1 0.01 91.19 Subarachnoid haemorrhage | 2 0.02 91.21 Subcutaneous abscess | 4 0.04 91.25 Subcutaneous haematoma | 1 0.01 91.26 Substance abuse | 2 0.02 91.28 Substance use | 1 0.01 91.29 Sudden death | 3 0.03 91.32 Sudden hearing loss | 2 0.02 91.34 Suffocation feeling | 2 0.02 91.36 Suicidal behaviour | 3 0.03 91.39 Suicidal ideation | 8 0.08 91.47 Suicide attempt | 12 0.12 91.59 Sunburn | 1 0.01 91.60 Supraventricular extrasystoles | 2 0.02 91.62 Supraventricular tachycardia | 5 0.05 91.67 Surgery | 6 0.06 91.73 Surgical failure | 1 0.01 91.74 Suspected transmission of an infectio.. | 1 0.01 91.75 Swelling | 11 0.11 91.86 Swelling face | 4 0.04 91.90 Swollen tongue | 1 0.01 91.91 Syncope | 16 0.16 92.07 Synovial cyst | 2 0.02 92.09 Systemic candida | 1 0.01 92.10 Systemic lupus erythematosus | 5 0.05 92.15 Tachycardia | 10 0.10 92.25 Tachypnoea | 1 0.01 92.26 Takayasu's arteritis | 1 0.01 92.27 Talipes | 2 0.02 92.29 Tardive dyskinesia | 2 0.02 92.31 Temperature intolerance | 2 0.02 92.33 Temporomandibular joint syndrome | 1 0.01 92.34 Tendon disorder | 4 0.04 92.38 Tendon rupture | 4 0.04 92.42 Tendon sheath incision | 1 0.01 92.43 Tendonitis | 8 0.08 92.51 Tenoplasty | 1 0.01 92.52 Tenosynovitis | 1 0.01 92.53 Tenosynovitis stenosans | 1 0.01 92.54 Testicular cancer metastatic | 1 0.01 92.55 Testicular pain | 2 0.02 92.57 Tetanus | 2 0.02 92.59 Tetany | 2 0.02 92.61 Thalamus haemorrhage | 1 0.01 92.62 Therapeutic response changed | 1 0.01 92.63 Therapeutic response decreased | 7 0.07 92.70 Therapeutic response increased | 1 0.01 92.71 Therapeutic response shortened | 2 0.02 92.73 Therapeutic response unexpected | 2 0.02 92.75 Therapy cessation | 3 0.03 92.78 Therapy non-responder | 2 0.02 92.80 Thinking abnormal | 4 0.04 92.84 Thirst | 3 0.03 92.87 Thoracic vertebral fracture | 2 0.02 92.89 Throat cancer | 1 0.01 92.90 Throat clearing | 1 0.01 92.91 Throat irritation | 3 0.03 92.94 Throat lesion | 1 0.01 92.95 Throat tightness | 1 0.01 92.96 Thrombocytopenia | 32 0.32 93.28 Thrombocytosis | 1 0.01 93.29 Thrombophlebitis | 1 0.01 93.30 Thrombophlebitis septic | 1 0.01 93.31 Thrombosis | 11 0.11 93.42 Thrombosis prophylaxis | 1 0.01 93.43 Thrombotic microangiopathy | 3 0.03 93.46 Thrombotic thrombocytopenic purpura | 2 0.02 93.48 Thyroid adenoma | 1 0.01 93.49 Thyroid cancer | 2 0.02 93.51 Thyroid disorder | 5 0.05 93.56 Thyroid function test abnormal | 2 0.02 93.58 Thyroid mass | 1 0.01 93.59 Thyroidectomy | 2 0.02 93.61 Thyroiditis | 1 0.01 93.62 Thyroxine decreased | 1 0.01 93.63 Thyroxine free decreased | 2 0.02 93.65 Tibia fracture | 4 0.04 93.69 Tinea infection | 1 0.01 93.70 Tinnitus | 12 0.12 93.82 Toe amputation | 1 0.01 93.83 Tongue biting | 1 0.01 93.84 Tongue blistering | 1 0.01 93.85 Tongue discolouration | 1 0.01 93.86 Tongue disorder | 1 0.01 93.87 Tongue injury | 1 0.01 93.88 Tongue oedema | 1 0.01 93.89 Tonic convulsion | 1 0.01 93.90 Tonsillar disorder | 2 0.02 93.92 Tonsillectomy | 7 0.07 93.99 Tooth abscess | 1 0.01 94.00 Tooth disorder | 20 0.20 94.20 Tooth extraction | 11 0.11 94.31 Tooth fracture | 7 0.07 94.38 Tooth infection | 2 0.02 94.40 Tooth injury | 1 0.01 94.41 Tooth loss | 3 0.03 94.44 Tooth repair | 1 0.01 94.45 Tourette's disorder | 1 0.01 94.46 Toxic encephalopathy | 2 0.02 94.48 Toxic epidermal necrolysis | 2 0.02 94.50 Toxic skin eruption | 2 0.02 94.52 Toxicity to various agents | 11 0.11 94.63 Transaminases increased | 3 0.03 94.66 Transfusion | 4 0.04 94.70 Transient ischaemic attack | 5 0.05 94.75 Transient tachypnoea of the newborn | 1 0.01 94.76 Transplant rejection | 2 0.02 94.78 Transposition of the great vessels | 1 0.01 94.79 Transverse sinus thrombosis | 1 0.01 94.80 Traumatic haemorrhage | 1 0.01 94.81 Treatment failure | 3 0.03 94.84 Treatment noncompliance | 7 0.07 94.91 Tremor | 17 0.17 95.08 Trichophytic granuloma | 1 0.01 95.09 Tricuspid valve incompetence | 1 0.01 95.10 Trigger finger | 2 0.02 95.12 Trismus | 1 0.01 95.13 Trisomy 21 | 1 0.01 95.14 Troponin increased | 1 0.01 95.15 Trousseau's syndrome | 1 0.01 95.16 Tuberculosis | 1 0.01 95.17 Tubulointerstitial nephritis | 6 0.06 95.23 Tumour excision | 1 0.01 95.24 Tumour haemorrhage | 1 0.01 95.25 Tumour lysis syndrome | 3 0.03 95.28 Tumour pain | 1 0.01 95.29 Tympanic membrane perforation | 2 0.02 95.31 Type 2 diabetes mellitus | 6 0.06 95.37 Type IIa hyperlipidaemia | 1 0.01 95.38 Type IV hypersensitivity reaction | 1 0.01 95.39 Type V hyperlipidaemia | 2 0.02 95.41 Ulcer | 1 0.01 95.42 Ulcer haemorrhage | 1 0.01 95.43 Ulna fracture | 7 0.07 95.50 Umbilical cord abnormality | 1 0.01 95.51 Umbilical cord cyst | 1 0.01 95.52 Underdose | 5 0.05 95.57 Undifferentiated connective tissue di.. | 1 0.01 95.58 Unevaluable event | 4 0.04 95.62 Unresponsive to stimuli | 1 0.01 95.63 Upper gastrointestinal haemorrhage | 1 0.01 95.64 Upper limb fracture | 8 0.08 95.72 Upper respiratory tract infection | 10 0.10 95.82 Upper respiratory tract inflammation | 1 0.01 95.83 Upper-airway cough syndrome | 2 0.02 95.85 Ureteral disorder | 2 0.02 95.87 Ureteral stent insertion | 1 0.01 95.88 Urinary bladder rupture | 1 0.01 95.89 Urinary bladder suspension | 2 0.02 95.91 Urinary incontinence | 10 0.10 96.01 Urinary retention | 7 0.07 96.08 Urinary retention postoperative | 1 0.01 96.09 Urinary tract disorder | 2 0.02 96.11 Urinary tract infection | 34 0.34 96.45 Urinary tract infection bacterial | 1 0.01 96.46 Urinary tract infection enterococcal | 1 0.01 96.47 Urinary tract obstruction | 2 0.02 96.49 Urine abnormality | 1 0.01 96.50 Urine calcium decreased | 1 0.01 96.51 Urine output decreased | 1 0.01 96.52 Urogenital disorder | 1 0.01 96.53 Urogenital fistula | 1 0.01 96.54 Urosepsis | 2 0.02 96.56 Urticaria | 11 0.11 96.67 Uterine cancer | 1 0.01 96.68 Uterine carcinoma in situ | 1 0.01 96.69 Uterine dilation and curettage | 2 0.02 96.71 Uterine disorder | 2 0.02 96.73 Uterine leiomyoma | 5 0.05 96.78 Uterine mass | 1 0.01 96.79 Uterovaginal prolapse | 1 0.01 96.80 Uveitis | 3 0.03 96.83 Vaginal discharge | 1 0.01 96.84 Vaginal disorder | 1 0.01 96.85 Vaginal infection | 1 0.01 96.86 Vaginal prolapse | 1 0.01 96.87 Vaginoperineorrhaphy | 1 0.01 96.88 Varicose vein | 5 0.05 96.93 Varicose vein operation | 1 0.01 96.94 Vascular access complication | 1 0.01 96.95 Vascular calcification | 2 0.02 96.97 Vascular operation | 1 0.01 96.98 Vascular rupture | 1 0.01 96.99 Vasculitis | 3 0.03 97.02 Vasodilatation | 1 0.01 97.03 Vena cava thrombosis | 2 0.02 97.05 Venoocclusive liver disease | 3 0.03 97.08 Venous injury | 1 0.01 97.09 Venous operation | 1 0.01 97.10 Venous thrombosis | 1 0.01 97.11 Ventricular arrhythmia | 1 0.01 97.12 Ventricular extrasystoles | 2 0.02 97.14 Ventricular tachycardia | 1 0.01 97.15 Vertebral column mass | 1 0.01 97.16 Vertebral lesion | 1 0.01 97.17 Vertebral wedging | 1 0.01 97.18 Vertebrobasilar insufficiency | 1 0.01 97.19 Vertigo | 6 0.06 97.25 Very low density lipoprotein increased | 1 0.01 97.26 Viral cardiomyopathy | 2 0.02 97.28 Viral infection | 4 0.04 97.32 Viral upper respiratory tract infection | 2 0.02 97.34 Virologic failure | 1 0.01 97.35 Vision blurred | 13 0.13 97.48 Visual acuity reduced | 5 0.05 97.53 Visual field defect | 1 0.01 97.54 Visual impairment | 25 0.25 97.79 Vital functions abnormal | 1 0.01 97.80 Vitamin C deficiency | 1 0.01 97.81 Vitamin D decreased | 2 0.02 97.83 Vitamin D deficiency | 24 0.24 98.07 Vitello-intestinal duct remnant | 1 0.01 98.08 Vitreous detachment | 2 0.02 98.10 Vitreous floaters | 2 0.02 98.12 Vitreous haemorrhage | 2 0.02 98.14 Vitreous opacities | 1 0.01 98.15 Vocal cord disorder | 1 0.01 98.16 Vogt-Koyanagi-Harada syndrome | 1 0.01 98.17 Volvulus | 1 0.01 98.18 Vomiting | 44 0.44 98.62 Vomiting projectile | 1 0.01 98.63 Vulvovaginal burning sensation | 1 0.01 98.64 Vulvovaginal discomfort | 1 0.01 98.65 Vulvovaginal dryness | 3 0.03 98.68 Vulvovaginal mycotic infection | 2 0.02 98.70 Vulvovaginal pain | 1 0.01 98.71 Walking aid user | 2 0.02 98.73 Water intoxication | 1 0.01 98.74 Weight abnormal | 1 0.01 98.75 Weight decreased | 28 0.28 99.03 Weight gain poor | 2 0.02 99.05 Weight increased | 21 0.21 99.26 Wheelchair user | 2 0.02 99.28 Wheezing | 8 0.08 99.36 White blood cell count abnormal | 1 0.01 99.37 White blood cell count decreased | 17 0.17 99.54 White blood cell count increased | 4 0.04 99.58 White blood cell disorder | 1 0.01 99.59 Withdrawal syndrome | 10 0.10 99.69 Wound | 5 0.05 99.74 Wound complication | 1 0.01 99.75 Wound decomposition | 1 0.01 99.76 Wound dehiscence | 3 0.03 99.79 Wound haemorrhage | 1 0.01 99.80 Wound infection | 2 0.02 99.82 Wound infection pseudomonas | 1 0.01 99.83 Wrist fracture | 5 0.05 99.88 Wrist surgery | 3 0.03 99.91 Wrong technique in product usage proc.. | 7 0.07 99.98 X-ray of pelvis and hip abnormal | 1 0.01 99.99 Yellow skin | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 19 Jun 2018